@NP	Olfactory Ensheathing Cells	12
@NP	the Transected Dorsal Funiculus Bridge the Lesion	58
@NP	the Transected Dorsal Funiculus Bridge	58
@NP	the Lesion	97
@NP	Form Myelin Masanori Sasaki ,1,2 Karen L.	112
@NP	Form Myelin Masanori	112
@NP	Sasaki ,1,2 Karen L.	134
@NP	Lankford ,1,2 Micheas Zemedkun ,1,2 and Jeffery D.	154
@NP	Lankford ,1,2 Micheas Zemedkun	154
@NP	,1,2 and Jeffery D.	183
@NP	,1,2	183
@NP	Jeffery D.	192
@NP	Kocsis1 ,2 1Department	203
@NP	Neurology and Center	228
@NP	Neuroscience and Regeneration Research	253
@NP	Yale University School of Medicine	293
@NP	Yale University School	293
@NP	Medicine	319
@NP	New Haven , Connecticut 06510	329
@NP	New Haven	329
@NP	Connecticut 06510	340
@NP	2Rehabilitation Research Center	363
@NP	Veterans Affairs Medical Center	396
@NP	West Haven	429
@NP	Connecticut 06516 Olfactory ensheathing cells -LRB- OECs -RRB-	441
@NP	Connecticut	441
@NP	06516 Olfactory ensheathing cells -LRB- OECs -RRB-	453
@NP	06516 Olfactory ensheathing cells	453
@NP	OECs	489
@NP	the olfactory bulbs	509
@NP	adult transgenic Sprague Dawley -LRB- SD -RRB- rats	532
@NP	SD	565
@NP	green fluorescent protein -LRB- GFP -RRB- were transplanted into a dorsal	585
@NP	green fluorescent protein	585
@NP	GFP	612
@NP	a dorsal	640
@NP	spinal cord transection lesion of SD rats	649
@NP	spinal cord transection lesion	649
@NP	SD rats	683
@NP	Five weeks	692
@NP	transplantation	709
@NP	the cells	726
@NP	the lesion zone	752
@NP	axons that bridged the transection site	802
@NP	axons	802
@NP	the transection site	821
@NP	the highest density ofGFPcells	852
@NP	the lesion zone	894
@NP	somecells	910
@NP	the lesion area	958
@NP	axons spanning the lesion	986
@NP	axons	986
@NP	the lesion	1001
@NP	discrete bundles encapsulated by a cellular element	1029
@NP	discrete bundles	1029
@NP	a cellular element	1062
@NP	Electron micrographs of spinal cords immunostained with an anti-GFP antibody	1082
@NP	Electron micrographs	1082
@NP	spinal cords immunostained with an anti-GFP antibody	1106
@NP	spinal cords	1106
@NP	an anti-GFP antibody	1138
@NP	a majority of the peripheral-like myelinated axons	1174
@NP	a majority	1174
@NP	the peripheral-like myelinated axons	1188
@NP	donor OECs	1243
@NP	Open-field locomotor behavior	1255
@NP	the OEC transplantation group	1315
@NP	transplanted OECs derived from the adult olfactory bulb	1352
@NP	transplanted OECs	1352
@NP	the adult olfactory bulb	1383
@NP	a spinal cord transection site and form myelin	1453
@NP	a spinal cord transection site	1453
@NP	form myelin	1488
@NP	This pattern of repair	1501
@NP	This pattern	1501
@NP	repair	1517
@NP	improved locomotion	1543
@NP	Introduction Adult olfactory receptor neurons	1565
@NP	turnover	1631
@NP	an endogenous progenitor pool	1645
@NP	their nascent axons	1680
@NP	the olfactory nerves	1713
@NP	the PNS	1744
@NP	CNS interface	1752
@NP	they	1773
@NP	new synaptic connections	1783
@NP	the olfactory bulb -LRB- Graziadei et al. , 1978 -RRB-	1811
@NP	the olfactory bulb	1811
@NP	Graziadei	1831
@NP	et al. , 1978	1841
@NP	et al.	1841
@NP	1978	1849
@NP	A specialized glial cell , the olfactory ensheathing cell -LRB- OEC -RRB- ,	1856
@NP	A specialized glial cell	1856
@NP	the olfactory ensheathing cell -LRB- OEC -RRB-	1882
@NP	the olfactory ensheathing cell	1882
@NP	OEC	1914
@NP	olfactory receptor neurons	1939
@NP	their peripheral origin	1971
@NP	their central projection	1998
@NP	the outer nerve layer of the olfactory bulb -LRB- Doucette , 1991 -RRB-	2026
@NP	the outer nerve layer	2026
@NP	the olfactory bulb -LRB- Doucette , 1991 -RRB-	2051
@NP	the olfactory bulb	2051
@NP	Doucette , 1991	2071
@NP	Doucette	2071
@NP	1991	2081
@NP	This apparent support role of OECs in axonal growth in the adult CNS	2088
@NP	This apparent support role	2088
@NP	OECs in axonal growth in the adult CNS	2118
@NP	OECs	2118
@NP	axonal growth in the adult CNS	2126
@NP	axonal growth	2126
@NP	the adult CNS	2143
@NP	extensive research	2169
@NP	the potential of OEC transplants	2197
@NP	the potential	2197
@NP	OEC transplants	2214
@NP	axonal regeneration and functional recovery	2243
@NP	spinal cord injury models	2290
@NP	Li	2317
@NP	et al. , 1997 , 1998 ; Ramon	2320
@NP	et al.	2320
@NP	1997	2328
@NP	1998	2334
@NP	Ramon	2340
@NP	Cueto	2347
@NP	et al. , 1998 , 2000	2353
@NP	et al.	2353
@NP	1998	2361
@NP	2000	2367
@NP	Imaizumi	2373
@NP	et al. , 2000a , b	2382
@NP	et al.	2382
@NP	2000a	2390
@NP	b	2396
@NP	Transplantation of OECs into spinal cord injury models	2400
@NP	Transplantation	2400
@NP	OECs into spinal cord injury models	2419
@NP	OECs	2419
@NP	spinal cord injury models	2429
@NP	some degree	2464
@NP	axonal regeneration and functional improvement	2479
@NP	transplantation	2536
@NP	Lu	2564
@NP	et al. , 2002 ; Keyvan-Fouladi et al. , 2003	2567
@NP	et al.	2567
@NP	2002 ; Keyvan-Fouladi et al.	2575
@NP	2002	2575
@NP	Keyvan-Fouladi et al.	2581
@NP	Keyvan-Fouladi	2581
@NP	et al.	2596
@NP	2003	2604
@NP	axons	2622
@NP	the lesion site	2637
@NP	a characteristic peripheral pattern	2658
@NP	myelination similar to that of Schwann cell -LRB- SC -RRB-	2697
@NP	myelination similar to that of Schwann cell	2697
@NP	myelination	2697
@NP	that of Schwann cell	2720
@NP	that	2720
@NP	Schwann cell	2728
@NP	SC	2742
@NP	myelination -LRB- Li et al. , 1997 , 1998 ; Imaizumi et al. , 1998 , 2000a -RRB-	2746
@NP	myelination	2746
@NP	Li et al. , 1997 , 1998 ; Imaizumi et al. , 1998 , 2000a	2759
@NP	Li et al.	2759
@NP	Li	2759
@NP	et al.	2762
@NP	1997 , 1998 ; Imaizumi et al.	2770
@NP	1997 , 1998	2770
@NP	1997	2770
@NP	1998	2776
@NP	Imaizumi et al.	2782
@NP	Imaizumi	2782
@NP	et al.	2791
@NP	1998 , 2000a	2799
@NP	1998	2799
@NP	2000a	2805
@NP	Spinal cord injuries without OEC transplants	2813
@NP	Spinal cord injuries	2813
@NP	OEC transplants	2842
@NP	limited SC-like myelination	2867
@NP	invasion	2912
@NP	the injury site	2924
@NP	endogenous SCs	2945
@NP	Brook	2961
@NP	et al. , 1998	2967
@NP	et al.	2967
@NP	1998	2975
@NP	Imaizumi et al. , 2000a , b	2981
@NP	Imaizumi	2981
@NP	et al. , 2000a , b	2990
@NP	et al.	2990
@NP	2000a	2998
@NP	b	3004
@NP	Namiki et al. , 2000	3007
@NP	Namiki	3007
@NP	et al. , 2000	3014
@NP	et al.	3014
@NP	2000	3022
@NP	Takami et al. , 2002	3028
@NP	Takami	3028
@NP	et al. , 2002	3035
@NP	et al.	3035
@NP	2002	3043
@NP	precursor cells	3066
@NP	The degree	3083
@NP	OECs	3103
@NP	injury sites	3127
@NP	they	3164
@NP	endogenous myelin repair mechanisms	3195
@NP	Takami et al. -LRB- 2002 -RRB-	3249
@NP	Takami et al.	3249
@NP	Takami	3249
@NP	et al.	3256
@NP	2002	3264
@NP	SC but not OEC transplantation	3284
@NP	SC	3284
@NP	OEC transplantation	3295
@NP	OEC	3295
@NP	transplantation	3299
@NP	improved hindlimb locomotor function	3326
@NP	OECs in culture	3889
@NP	OECs	3889
@NP	culture	3897
@NP	characteristics of astrocytes , SCs , and oligodendrocytes	3929
@NP	characteristics	3929
@NP	astrocytes , SCs , and oligodendrocytes	3948
@NP	they	3997
@NP	a number	4010
@NP	trophic factors , transcription factors , and extracellular matrix molecules	4022
@NP	trophic factors	4022
@NP	transcription factors	4039
@NP	extracellular matrix molecules	4066
@NP	Ramon-Cueto and Avila , 1998 ; Chuah and West , 2002 ; Au and Roskams , 2003	4098
@NP	Ramon-Cueto and Avila	4098
@NP	Ramon-Cueto	4098
@NP	Avila	4114
@NP	1998 ; Chuah and West	4121
@NP	1998	4121
@NP	Chuah and West	4127
@NP	2002 ; Au and Roskams , 2003	4143
@NP	2002	4143
@NP	Au and Roskams , 2003	4149
@NP	Au and Roskams	4149
@NP	2003	4165
@NP	endogenous cell invasion	4193
@NP	angiogenesis and activation of progenitor cells	4230
@NP	angiogenesis and activation	4230
@NP	progenitor cells	4261
@NP	the present study	4282
@NP	we	4301
@NP	OECs	4317
@NP	adult green fluorescent protein	4336
@NP	GFP	4369
@NP	transgenic rats	4385
@NP	a dorsal funiculus transection model in the rat	4406
@NP	a dorsal funiculus transection model	4406
@NP	the rat	4446
@NP	Immuno	4455
@NP	GFP	4476
@NP	electron microscopy	4493
@NP	ultrastructural identification of GFP myelin-forming cells	4521
@NP	ultrastructural identification	4521
@NP	GFP myelin-forming cells	4555
@NP	We	4581
@NP	transplanted OECs	4596
@NP	the injury site of a dorsal funiculus transection	4629
@NP	the injury site	4629
@NP	a dorsal funiculus transection	4648
@NP	axons spanning the lesion site	4725
@NP	axons	4725
@NP	the lesion site	4740
@NP	myelin	4766
@NP	This set of anatomic events	4774
@NP	This set	4774
@NP	anatomic events	4786
@NP	improved hindlimb locomotor function	4821
@NP	Materials and Methods Isolation and characterization of donor OECs .	4860
@NP	Materials and Methods	4860
@NP	Materials	4860
@NP	Methods	4874
@NP	Isolation and characterization of donor OECs	4882
@NP	Isolation and characterization	4882
@NP	donor OECs	4916
@NP	Freshly isolated donor OECs	4928
@NP	an exacting procedure	4976
@NP	differential dissociation and attachment rates of subtypes of cells	5013
@NP	differential dissociation and attachment rates	5013
@NP	subtypes of cells	5063
@NP	subtypes	5063
@NP	cells	5075
@NP	other cell types	5100
@NP	a highly pure population of OECs	5128
@NP	a highly pure population	5128
@NP	OECs	5156
@NP	Olfactory bulbs	5162
@NP	4	5196
@NP	8-week-old transgenic rats	5202
@NP	GFP	5240
@NP	`` green rat '' CZ-004 , SD-Tg -LRB- Act-EGFP -RRB- CZ-004Osb	5245
@NP	`` green rat ''	5245
@NP	CZ-004 , SD-Tg -LRB- Act-EGFP -RRB- CZ-004Osb	5257
@NP	SLC , Shizuoka , Japan	5291
@NP	SLC	5291
@NP	Shizuoka	5296
@NP	Japan	5306
@NP	meninges	5335
@NP	The caudal onethird of the bulb	5345
@NP	The caudal onethird	5345
@NP	the bulb	5368
@NP	as much white matter as possible to isolate the outer nerve layer	5414
@NP	as much white matter	5414
@NP	possible to isolate the outer nerve layer	5438
@NP	the outer nerve	5458
@NP	The tissue	5481
@NP	finely with a pair scalpel blades -LRB- # 10 -RRB-	5503
@NP	finely with a pair scalpel blades	5503
@NP	a pair scalpel	5515
@NP	# 10	5538
@NP	culture plastic	5546
@NP	Nonadherent pieces of tissue	5563
@NP	Nonadherent pieces	5563
@NP	tissue	5585
@NP	the culture dish	5609
@NP	25 min	5644
@NP	collagenase A -LRB- 0.75 mg/ml ; Roche , Indianapolis , IN -RRB-	5654
@NP	collagenase A	5654
@NP	0.75 mg/ml ; Roche , Indianapolis	5669
@NP	0.75 mg/ml	5669
@NP	Roche , Indianapolis	5681
@NP	collagenase D -LRB- 0.75 mg/ml ; Roche -RRB-	5707
@NP	collagenase D	5707
@NP	0.75 mg/ml ; Roche	5722
@NP	0.75 mg/ml	5722
@NP	Roche	5734
@NP	papain -LRB- 12 U/ml ; Worthington , Lakewood , NJ -RRB-	5746
@NP	papain	5746
@NP	12 U/ml ; Worthington , Lakewood , NJ	5754
@NP	12 U/ml	5754
@NP	Worthington , Lakewood , NJ	5763
@NP	calcium-free complete saline solution with trace cysteine for 25 min	5793
@NP	calcium-free complete saline solution	5793
@NP	trace cysteine for 25 min	5836
@NP	trace cysteine	5836
@NP	25 min	5855
@NP	37 °C on a rotary shaker in a CO2 incubator	5865
@NP	37 °C	5865
@NP	a rotary shaker in a CO2 incubator	5873
@NP	a rotary shaker	5873
@NP	a CO2 incubator	5892
@NP	Tissue	5909
@NP	7 min	5941
@NP	300 x g	5950
@NP	300	5950
@NP	g	5956
@NP	the supernatant	5959
@NP	tissue	5994
@NP	2 ml of DMEM -LRB- Invitrogen , Carlsbad , CA -RRB-	6020
@NP	2 ml	6020
@NP	DMEM -LRB- Invitrogen , Carlsbad , CA -RRB-	6027
@NP	DMEM	6027
@NP	Invitrogen	6033
@NP	Carlsbad	6045
@NP	CA	6055
@NP	10 % FCS	6064
@NP	very gentle mechanical trituration first witha5ml culture pipette	6078
@NP	very gentle mechanical trituration	6078
@NP	first witha5ml culture pipette	6113
@NP	then with two fire-polished silicone-coated pasture pipettes	6148
@NP	then	6148
@NP	two fire-polished silicone-coated pasture pipettes	6158
@NP	successively reduced diameters	6214
@NP	The volume of media	6246
@NP	The volume	6246
@NP	media	6260
@NP	20 ml	6295
@NP	undissociated pieces of tissue	6306
@NP	undissociated pieces	6306
@NP	tissue	6330
@NP	2 min	6364
@NP	the cell suspension	6390
@NP	another culture tube and centrifuging	6413
@NP	another culture tube	6413
@NP	centrifuging	6438
@NP	Cells	6462
@NP	1 hr in a culture flask	6518
@NP	1 hr	6518
@NP	a culture flask	6526
@NP	37 °C in a CO2 incubator	6545
@NP	37 °C	6545
@NP	a CO2 incubator	6553
@NP	Nonadherent cells	6570
@NP	DMEM	6616
@NP	cells	6626
@NP	three times	6665
@NP	DMEM	6680
@NP	cells	6719
@NP	3.0	6728
@NP	10 ^	6734
@NP	4 cells/µl	6737
@NP	transplantation	6760
@NP	transplantations	6795
@NP	the remaining OECs	6828
@NP	10 ml of culture media	6867
@NP	10 ml	6867
@NP	culture media	6876
@NP	8-well poly-L-lysine-coated chamber slides	6913
@NP	inDMEMwith 10 %	6956
@NP	inDMEMwith	6956
@NP	FCS and penicillin -- streptomycin	6971
@NP	3 -- 7 d	7010
@NP	3	7010
@NP	cells	7017
@NP	10 min in icecold methanol	7038
@NP	10 min	7038
@NP	icecold methanol	7048
@NP	primary antibody	7082
@NP	4 °C	7112
@NP	The antibodies used	7117
@NP	The antibodies	7117
@NP	rabbit anti-p75 -LRB- 1:1000 ; Chemicon , Temecula , CA -RRB-	7142
@NP	rabbit anti-p75	7142
@NP	1:1000 ; Chemicon , Temecula , CA	7159
@NP	1:1000	7159
@NP	Chemicon , Temecula , CA	7167
@NP	mouse monoclonal anti-S100 -LRB- 1:1000 ; Chemicon -RRB-	7192
@NP	mouse monoclonal anti-S100	7192
@NP	1:1000 ; Chemicon	7220
@NP	1:1000	7220
@NP	Chemicon	7228
@NP	rabbit anti-cow S100 -LRB- 1:400 ; Dako , Carpinteria , CA -RRB-	7239
@NP	rabbit anti-cow S100	7239
@NP	1:400 ; Dako , Carpinteria , CA	7261
@NP	1:400	7261
@NP	Dako , Carpinteria , CA	7268
@NP	mouse monoclonal anti-GFAP	7296
@NP	1:1000 , SMI22 ; Sternberger Monoclonals , Lutherville , MD	7324
@NP	1:1000	7324
@NP	SMI22 ; Sternberger Monoclonals , Lutherville	7332
@NP	SMI22	7332
@NP	Sternberger Monoclonals , Lutherville	7339
@NP	Sternberger Monoclonals	7339
@NP	Lutherville	7364
@NP	MD	7377
@NP	The primary antibodies	7382
@NP	Alexa Fluor 488 goat anti-mouse	7426
@NP	Alexa Fluor	7426
@NP	488 goat	7438
@NP	1:1000 ; Molecular Probes	7459
@NP	1:1000	7459
@NP	Molecular Probes	7467
@NP	Eugene , OR	7485
@NP	Eugene	7485
@NP	OR	7493
@NP	Alexa Fluor 594 goat antirabbit -LRB- 1:1000 ; Molecular Probes -RRB-	7501
@NP	Alexa Fluor	7501
@NP	594 goat antirabbit -LRB- 1:1000 ; Molecular Probes -RRB-	7513
@NP	594 goat antirabbit	7513
@NP	1:1000 ; Molecular Probes	7534
@NP	1:1000	7534
@NP	Molecular Probes	7542
@NP	6 hr at room temperature	7585
@NP	6 hr	7585
@NP	room temperature	7593
@NP	a shaker	7613
@NP	Hoechst 33358 -LRB- 1 : 1000 ; Molecular Probes -RRB- for 1 hr	7646
@NP	Hoechst 33358 -LRB- 1 : 1000 ; Molecular Probes -RRB-	7646
@NP	Hoechst 33358	7646
@NP	1 : 1000 ; Molecular Probes	7661
@NP	1 : 1000	7661
@NP	Molecular Probes	7670
@NP	1 hr	7692
@NP	room temperature on a shaker	7700
@NP	room temperature	7700
@NP	a shaker	7720
@NP	Random areas in each well	7730
@NP	Random areas	7730
@NP	each well	7746
@NP	appropriate wavelengths	7777
@NP	a Spot camera -LRB- Diagnostic Instruments , Sterling Heights , MI -RRB-	7806
@NP	a Spot camera	7806
@NP	Diagnostic Instruments , Sterling Heights , MI	7821
@NP	Diagnostic Instruments	7821
@NP	Sterling Heights	7845
@NP	MI	7863
@NP	Spot Advanced software	7871
@NP	The percentages of p75 - , S100 - , and GFAPpositive cells	7895
@NP	The percentages	7895
@NP	p75	7914
@NP	S100	7920
@NP	GFAPpositive cells	7931
@NP	merged photographs	7966
@NP	Hoechst nuclear staining	7990
@NP	Dorsal funiculus transection .	8016
@NP	Dorsal	8016
@NP	funiculus transection	8023
@NP	Experiments	8046
@NP	accordance	8076
@NP	National Institutes of Health guidelines	8092
@NP	National Institutes	8092
@NP	Health guidelines	8115
@NP	the care and use of laboratory animals	8137
@NP	the care and use	8137
@NP	laboratory animals	8157
@NP	the Yale University Institutional Animal Care and Use Committee	8181
@NP	all animal protocols	8254
@NP	Adult female Sprague Dawley rats -LRB- 150 -- 179 gm -RRB-	8276
@NP	Adult female Sprague Dawley rats	8276
@NP	150 -- 179 gm	8310
@NP	150	8310
@NP	179 gm	8314
@NP	ketamine/xylazine	8345
@NP	90/4 mg/kg , i.p.	8364
@NP	90/4 mg/kg	8364
@NP	sterile technique	8389
@NP	a T9 laminectomy	8408
@NP	dura	8444
@NP	the spinal cord	8470
@NP	The dorsal vein of the spinal cord	8487
@NP	The dorsal vein	8487
@NP	the spinal cord	8506
@NP	the dorsal funiculus	8542
@NP	Neumann and Woolf	8579
@NP	1999	8598
@NP	an ophthalmic scalpel -LRB- P-715 ; Feather Safety Co. , Osaka , Japan -RRB-	8610
@NP	an ophthalmic scalpel	8610
@NP	P-715 ; Feather Safety Co.	8633
@NP	P-715	8633
@NP	Feather Safety Co.	8640
@NP	Osaka , Japan	8660
@NP	Osaka	8660
@NP	Japan	8667
@NP	The overlying muscles and skin	8675
@NP	layers with 4-0 nylon sutures	8721
@NP	layers	8721
@NP	4-0 nylon sutures	8733
@NP	the animal	8756
@NP	a 37 °C heating pad	8793
@NP	This surgery	8813
@NP	paresis of the hindlimbs	8838
@NP	paresis	8838
@NP	the hindlimbs	8849
@NP	all animals subjected to the procedure	8866
@NP	all animals	8866
@NP	the procedure	8891
@NP	eating , drinking , or elimination	8924
@NP	OEC transplantation .	8958
@NP	OEC	8958
@NP	transplantation	8962
@NP	transection of the dorsal funiculus	8997
@NP	transection	8997
@NP	the dorsal funiculus	9012
@NP	freshly isolated OECs	9034
@NP	adult GFP-expressing rats , or vehicle alone -LRB- DMEM -RRB- ,	9069
@NP	adult GFP-expressing rats	9069
@NP	vehicle alone -LRB- DMEM -RRB-	9099
@NP	vehicle alone	9099
@NP	DMEM	9114
@NP	the dorsal funiculus	9140
@NP	a drawn glass micropipette	9167
@NP	Two injections	9195
@NP	just rostral and two just caudal	9220
@NP	just rostral	9220
@NP	two just caudal	9237
@NP	the lesion	9256
@NP	depths of 0.7 and 0.4 mm	9270
@NP	depths	9270
@NP	0.7 and 0.4 mm	9280
@NP	0.7	9280
@NP	0.4 mm	9288
@NP	an additional cell injection	9300
@NP	the transection site for a total of five injections	9345
@NP	the transection site	9345
@NP	a total of five injections	9370
@NP	a total	9370
@NP	five injections	9381
@NP	The injection volume	9398
@NP	1.0 µl per site	9423
@NP	1.0 µl	9423
@NP	site	9433
@NP	The OEC concentration	9439
@NP	3.0 x 10 ^ 4 cells/µl for a total of 1.5 x 10 ^ 5 cells transplanted per rat	9465
@NP	3.0	9465
@NP	10 ^ 4 cells/µl for a total of 1.5 x 10 ^ 5 cells transplanted per rat	9471
@NP	10 ^ 4 cells/µl for a total of 1.5	9471
@NP	10 ^ 4 cells/µl	9471
@NP	a total of 1.5	9489
@NP	a total	9489
@NP	1.5	9500
@NP	10 ^ 5 cells transplanted per rat	9506
@NP	10 ^ 5 cells	9506
@NP	rat	9534
@NP	The animals	9539
@NP	histological study	9569
@NP	5 weeks	9591
@NP	transplantation	9605
@NP	Immunohistochemistry procedures .	9622
@NP	Animals	9655
@NP	PBS	9697
@NP	4 % paraformaldehyde in PBS	9714
@NP	4 % paraformaldehyde	9714
@NP	PBS	9737
@NP	Cryostat sections -LRB- 25 µm -RRB- of spinal cord	9742
@NP	Cryostat sections -LRB- 25 µm -RRB-	9742
@NP	Cryostat sections	9742
@NP	25 µm	9761
@NP	spinal cord	9771
@NP	antibodies against neurofilament -LRB- NF ; 1:1000 ; Sigma , St.	9803
@NP	antibodies	9803
@NP	neurofilament -LRB- NF ; 1:1000 ; Sigma , St.	9822
@NP	neurofilament -LRB- NF ; 1:1000	9822
@NP	neurofilament	9822
@NP	NF ; 1:1000	9837
@NP	NF	9837
@NP	1:1000	9841
@NP	Sigma , St.	9849
@NP	Louis , MO -RRB-	9860
@NP	Louis	9860
@NP	fibronectin -LRB- FN ; 1:200 ; Molecular Probes -RRB-	9875
@NP	fibronectin	9875
@NP	FN	9888
@NP	1:200 ; Molecular Probes	9892
@NP	1:200	9892
@NP	Molecular Probes	9899
@NP	P0 -LRB- protein 0 -RRB- -LRB- 1:150 ;	9921
@NP	P0 -LRB- protein 0 -RRB-	9921
@NP	P0	9921
@NP	protein 0	9925
@NP	1:150	9937
@NP	Dr.	9958
@NP	Juan Archelos , University of Graz , Graz , Austria -RRB- .	9962
@NP	Juan Archelos	9962
@NP	University of Graz , Graz , Austria -RRB-	9977
@NP	University	9977
@NP	Graz , Graz , Austria -RRB-	9991
@NP	Graz	9991
@NP	Graz	9997
@NP	Austria	10003
@NP	Sections	10013
@NP	PBS	10042
@NP	appropriate secondary antibodies	10065
@NP	goat anti-mouse IgG	10109
@NP	Alexa Fluor 594 -LRB- 1:1000 ; Molecular Probes -RRB-	10129
@NP	Alexa Fluor 594	10129
@NP	1:1000 ; Molecular Probes	10146
@NP	1:1000	10146
@NP	Molecular Probes	10154
@NP	donkey anti-chicken rhodamine -LRB- 1:100 ; Chemicon -RRB-	10176
@NP	donkey anti-chicken rhodamine	10176
@NP	1:100 ; Chemicon	10207
@NP	1:100	10207
@NP	Chemicon	10214
@NP	solution	10236
@NP	2 hr	10249
@NP	PBS	10265
@NP	slides	10285
@NP	Control experiments	10293
@NP	the omission of primary or secondary antibodies	10327
@NP	the omission	10327
@NP	primary or secondary antibodies	10343
@NP	no staining	10382
@NP	The sections	10395
@NP	confocal microscopy -LRB- Nikon Eclipse E600 microscope ; Simple PCI software	10425
@NP	confocal microscopy -LRB- Nikon Eclipse E600 microscope	10425
@NP	Simple PCI software	10477
@NP	Compix Inc. , Imaging Systems , Cranberry Township , PA	10498
@NP	Compix Inc.	10498
@NP	Imaging Systems	10511
@NP	Cranberry Township	10528
@NP	PA	10548
@NP	conventional fluorescence microscopy	10560
@NP	Nikon Eclipse	10598
@NP	800 ; Spot RT Color CCD camera ; Diagnostic Instruments	10612
@NP	800	10612
@NP	Spot RT Color CCD camera	10617
@NP	Spot RT Color CCD	10617
@NP	camera	10635
@NP	Diagnostic Instruments	10643
@NP	Immuno-electron microscopy .	10668
@NP	Immuno-electron	10668
@NP	microscopy	10684
@NP	Animals	10696
@NP	PBS	10738
@NP	4 % paraformaldehyde -- 0.02 % glutaraldehyde in PBS	10755
@NP	4 % paraformaldehyde	10755
@NP	0.02 % glutaraldehyde in PBS	10775
@NP	0.02 % glutaraldehyde	10775
@NP	PBS	10799
@NP	Spinal cords	10804
@NP	postfixed overnight in 4 % paraformaldehyde	10833
@NP	postfixed overnight	10833
@NP	4 % paraformaldehyde	10856
@NP	3 % agar for vibratome sectioning	10893
@NP	3 % agar	10893
@NP	vibratome sectioning	10905
@NP	Freefloating sections -LRB- 150 mthick -RRB-	10927
@NP	Freefloating sections	10927
@NP	150 mthick	10950
@NP	2 % normal goat serum	10985
@NP	30 min	11010
@NP	Vibratome sections	11018
@NP	the lesion zone	11057
@NP	GFP cells	11078
@NP	fluorescence microscopy	11107
@NP	immunoperoxidase staining	11136
@NP	the sections	11163
@NP	rabbit anti-GFP antibody -LRB- 1:2000 ; Chemicon -RRB-	11196
@NP	rabbit anti-GFP antibody	11196
@NP	1:2000 ; Chemicon	11222
@NP	1:2000	11222
@NP	Chemicon	11230
@NP	overnight at 4 °C	11240
@NP	overnight	11240
@NP	4 °C	11253
@NP	The sections	11258
@NP	the Vectastain	11289
@NP	anti-rabbit ABC Elite kit	11304
@NP	Vector Laboratories	11331
@NP	Burlingame	11352
@NP	CA	11364
@NP	1 hr at room temparature	11372
@NP	1 hr	11372
@NP	room temparature	11380
@NP	the manufacturer 's instructions	11410
@NP	the manufacturer 's	11410
@NP	The sections	11443
@NP	1 % osmium tetroxide	11476
@NP	4 hr , dehydrated in graded ethanol solutions , and embedded in Epox-812	11500
@NP	4 hr	11500
@NP	ethanol solutions	11527
@NP	Epox-812	11562
@NP	Ernest Fullam	11572
@NP	Latham	11587
@NP	NY	11595
@NP	Thin plastic sections	11600
@NP	an ultramicrotome	11634
@NP	uranyl	11676
@NP	salts	11692
@NP	an EM902A electron microscope -LRB- Zeiss , Oberkochen , Germany -RRB-	11716
@NP	an EM902A electron microscope	11716
@NP	Zeiss	11747
@NP	Oberkochen	11754
@NP	Germany	11766
@NP	80 kV	11788
@NP	Morphometric analysis .	11795
@NP	Spinal cords	11818
@NP	Lankford et al. , 2002	11890
@NP	Lankford	11890
@NP	et al.	11899
@NP	2002	11907
@NP	One-micrometer semithin plastic sections	11914
@NP	0.25 mmintervals	11973
@NP	the lesion	11997
@NP	Axon	12009
@NP	cross-sectional area measurements	12025
@NP	the dorsal corticospinal tract -LRB- dCST -RRB- and dorsal column -LRB- DC -RRB-	12076
@NP	the dorsal corticospinal tract	12076
@NP	dCST	12108
@NP	dorsal column	12118
@NP	DC	12133
@NP	2 mm rostral and caudal to the midpoint of the lesion	12137
@NP	2 mm rostral	12137
@NP	caudal	12154
@NP	the midpoint of the lesion	12164
@NP	the midpoint	12164
@NP	the lesion	12180
@NP	a Nikon Microphot micoroscope -LRB- 100x -RRB-	12197
@NP	a Nikon Microphot micoroscope	12197
@NP	100x	12228
@NP	image analysis software -LRB- Bioquaont Novaprime -RRB-	12238
@NP	image analysis software	12238
@NP	Bioquaont Novaprime	12263
@NP	Hand counts	12285
@NP	axons within the lesion site	12316
@NP	axons	12316
@NP	the lesion site	12329
@NP	Measurements	12346
@NP	two	12372
@NP	fields -LRB- 50 x 37 µm -RRB- , positioned centrally	12384
@NP	fields -LRB- 50 x 37 µm -RRB-	12384
@NP	fields	12384
@NP	50 x 37 µm	12392
@NP	50	12392
@NP	37 µm	12397
@NP	the dCST or the DC	12429
@NP	the dCST	12429
@NP	the DC	12441
@NP	the intact , sham injection , and transplantation groups	12452
@NP	the intact	12452
@NP	sham injection	12464
@NP	transplantation groups	12484
@NP	One-way ANOVA	12508
@NP	a Dunnett 's test to identify specific pairwise differences between the means	12549
@NP	a Dunnett 's	12549
@NP	specific pairwise differences between the means	12578
@NP	specific pairwise differences	12578
@NP	the means	12616
@NP	Comparison analyses	12627
@NP	SPSS	12668
@NP	version 10.1.3	12673
@NP	Open-field locomotor testing .	12689
@NP	Open-field locomotor	12689
@NP	testing	12710
@NP	Behavioral analysis	12719
@NP	the OEC transplanted group -LRB- n = 20 -RRB-	12756
@NP	the OEC transplanted group	12756
@NP	n	12784
@NP	20	12788
@NP	the DMEM-injected group -LRB- n = 6 -RRB-	12796
@NP	the DMEM-injected group	12796
@NP	n	12821
@NP	6	12825
@NP	Preoperative testing	12829
@NP	2 d	12856
@NP	injury	12867
@NP	5 weeks	12903
@NP	surgery	12917
@NP	Locomotor function	12926
@NP	an observer	12961
@NP	the Basso , Beattie , and Bresnahan -LRB- BBB -RRB- locomotor rating scale	12987
@NP	Basso , Beattie , and Bresnahan -LRB- BBB -RRB-	12991
@NP	Basso , Beattie , and Bresnahan	12991
@NP	Basso	12991
@NP	Beattie	12998
@NP	Bresnahan	13011
@NP	BBB	13022
@NP	Basso	13051
@NP	et al. , 1995	13057
@NP	et al.	13057
@NP	1995	13065
@NP	reliability of hindlimb somatosensory testing	13081
@NP	reliability	13081
@NP	hindlimb somatosensory testing	13096
@NP	treatment outcome	13141
@NP	The Mann	13160
@NP	Whitney U test	13170
@NP	between-group comparison for BBB analysis	13203
@NP	between-group comparison	13203
@NP	BBB analysis	13232
@NP	Results Figure 1 .	13247
@NP	Results	13247
@NP	Figure 1	13255
@NP	Cross	13265
@NP	sections	13271
@NP	semithin plastic sections stained with methylene blue/Azure II	13281
@NP	semithin plastic sections	13281
@NP	methylene blue/Azure II	13320
@NP	spinal cord rostral	13348
@NP	-LRB- A -RRB-	13371
@NP	the level of -LRB- B -RRB- , and distal to -LRB- C -RRB-	13380
@NP	the level	13380
@NP	-LRB- B -RRB- , and distal to -LRB- C -RRB-	13393
@NP	-LRB- B -RRB- , and distal to	13393
@NP	-LRB- B -RRB-	13393
@NP	distal	13403
@NP	C	13415
@NP	the transection site	13418
@NP	5 weeks after injury	13440
@NP	5 weeks	13440
@NP	injury	13454
@NP	Rostral to the lesion , extensive axonal degeneration	13463
@NP	Rostral	13463
@NP	the lesion , extensive axonal degeneration	13474
@NP	the lesion	13474
@NP	extensive axonal degeneration	13486
@NP	the dorsal columns -LRB- DC ; A3 -RRB-	13532
@NP	the dorsal columns	13532
@NP	DC ; A3	13552
@NP	DC	13552
@NP	A3	13556
@NP	the dCST -LRB- A4 , A5 -RRB-	13571
@NP	the dCST	13571
@NP	A4 , A5	13581
@NP	A4	13581
@NP	A5	13585
@NP	Axonal degeneration	13590
@NP	the transection site	13627
@NP	B2 , B3	13649
@NP	B2	13649
@NP	B3	13653
@NP	the edge of the lesion -LRB- B4 , B5 -RRB-	13665
@NP	the edge	13665
@NP	the lesion -LRB- B4 , B5 -RRB-	13677
@NP	the lesion	13677
@NP	B4 , B5	13689
@NP	B4	13689
@NP	B5	13693
@NP	a modest number of axons with a peripheral pattern of myelination	13698
@NP	a modest number	13698
@NP	axons with a peripheral pattern of myelination	13717
@NP	axons	13717
@NP	a peripheral pattern of myelination	13728
@NP	a peripheral pattern	13728
@NP	myelination	13752
@NP	Caudal to the transection site , DC axons	13778
@NP	Caudal	13778
@NP	the transection site , DC axons	13788
@NP	the transection site	13788
@NP	DC axons	13810
@NP	C2 , C3	13832
@NP	C2	13832
@NP	C3	13836
@NP	dCST axons	13844
@NP	various stages of degeneration -LRB- C4 , C5 -RRB-	13863
@NP	various stages	13863
@NP	degeneration -LRB- C4 , C5 -RRB-	13881
@NP	degeneration	13881
@NP	C4 , C5	13895
@NP	C4	13895
@NP	C5	13899
@NP	Scale	13904
@NP	in C5	13916
@NP	A -- C , 1.0 mm ; A2 -- C2 , 0.4 mm ; A3 -- C3 , A4 -- C4 , 40µm ; A5	13923
@NP	A -- C , 1.0 mm ; A2 -- C2 , 0.4 mm ; A3 -- C3 , A4	13923
@NP	A -- C , 1.0 mm ; A2 -- C2 , 0.4 mm ; A3 -- C3	13923
@NP	C , 1.0 mm	13925
@NP	C	13925
@NP	1.0 mm	13928
@NP	A2 -- C2 , 0.4 mm ; A3	13936
@NP	A2	13936
@NP	C2 , 0.4 mm	13939
@NP	C2	13939
@NP	0.4 mm	13943
@NP	A3	13951
@NP	A4	13958
@NP	C4 , 40µm ; A5	13962
@NP	C4 , 40µm ;	13962
@NP	C4	13962
@NP	40µm	13966
@NP	A5	13972
@NP	C5 , 8.5 µm	13975
@NP	C5	13975
@NP	8.5 µm	13979
@NP	Figure 2 .	13987
@NP	Figure	13987
@NP	2	13994
@NP	OECs	13997
@NP	culture -LRB- 7 d -RRB-	14005
@NP	culture	14005
@NP	7 d	14014
@NP	nuclear staining -LRB- Hoechst -RRB-	14024
@NP	nuclear staining	14024
@NP	Hoechst	14042
@NP	p75 -LRB- A -RRB- , S100 -LRB- B -RRB- , and GFAP -LRB- D -RRB-	14073
@NP	p75 -LRB- A -RRB-	14073
@NP	p75	14073
@NP	A	14079
@NP	S100 -LRB- B -RRB-	14083
@NP	S100	14083
@NP	B	14090
@NP	GFAP -LRB- D -RRB-	14098
@NP	GFAP	14098
@NP	D	14105
@NP	Merged images	14109
@NP	S100 -LRB- C -RRB- and GFAP -LRB- E -RRB-	14126
@NP	S100	14126
@NP	C	14133
@NP	GFAP	14140
@NP	E	14147
@NP	immunostaining with p75	14150
@NP	immunostaining	14150
@NP	p75	14170
@NP	extensive colocalization	14184
@NP	> 95 % of p75	14210
@NP	> 95 %	14210
@NP	>	14210
@NP	p75	14218
@NP	+	14221
@NP	S100	14227
@NP	+	14231
@NP	F	14234
@NP	A control section with nuclear staining	14237
@NP	A control section	14237
@NP	nuclear staining	14260
@NP	secondary antibody but no primary antibody	14281
@NP	secondary antibody	14281
@NP	no primary antibody	14304
@NP	Scale bar : -LRB- in F -RRB- A -- F , 100µm .	14325
@NP	Scale bar : -LRB- in F -RRB-	14325
@NP	Scale bar :	14325
@NP	F	14340
@NP	F , 100µm	14346
@NP	F	14346
@NP	100µm	14349
@NP	Figure 3 .	14357
@NP	Figure	14357
@NP	3	14364
@NP	A , Sagittal frozen section showing distribution	14367
@NP	Sagittal	14370
@NP	section	14386
@NP	GFP-OECs	14418
@NP	the transection site	14445
@NP	B , Isolated fiber outside of the lesion zone	14467
@NP	B	14467
@NP	fiber outside of the lesion zone	14479
@NP	fiber	14479
@NP	the lesion zone	14496
@NP	GFP fluorescence	14528
@NP	C	14546
@NP	Higher-power micrograph	14549
@NP	boxed region in B showing node-like structure -LRB- arrow -RRB-	14576
@NP	boxed region	14576
@NP	B showing node-like structure	14592
@NP	arrow	14623
@NP	D , NF immunostaining	14631
@NP	intimate relationship between axons and GFP donor cells	14660
@NP	intimate relationship	14660
@NP	axons and GFP donor cells	14690
@NP	axons	14690
@NP	GFP donor cells	14700
@NP	Scale bars : A , 250µm ; B , 100µm ; C , 20µm ; D , 50µm .	14717
@NP	Scale bars	14717
@NP	A , 250µm	14729
@NP	A	14729
@NP	250µm	14732
@NP	B , 100µm	14739
@NP	B	14739
@NP	100µm	14742
@NP	C , 20µm	14749
@NP	C	14749
@NP	20µm	14752
@NP	D , 50µm	14758
@NP	D	14758
@NP	50µm	14761
@NP	Figure 4 .	14768
@NP	Figure	14768
@NP	4	14775
@NP	Semithin plastic sections	14778
@NP	methylene blue/Azure II	14817
@NP	the transection site 5 weeks	14849
@NP	the transection site	14849
@NP	5 weeks	14870
@NP	transplantation of OECs	14884
@NP	transplantation	14884
@NP	OECs	14903
@NP	A	14909
@NP	Low-power micrograph	14912
@NP	completeness of the transection	14941
@NP	completeness	14941
@NP	the transection	14957
@NP	the entire dorsal funiculus	14981
@NP	B1	15021
@NP	B2	15025
@NP	Higher-power micrographs	15029
@NP	groups of myelinated axons	15062
@NP	groups	15062
@NP	myelinated axons	15072
@NP	the lesion zone obtained from regions indicated in A.	15096
@NP	the lesion zone	15096
@NP	regions indicated in A.	15126
@NP	regions	15126
@NP	A.	15147
@NP	C , Higher-power micrograph from boxed region in B1 .	15150
@NP	C	15150
@NP	Higher-power micrograph from boxed region in B1	15153
@NP	Higher-power micrograph	15153
@NP	boxed region in B1	15182
@NP	boxed region	15182
@NP	B1	15198
@NP	the clustering of myelinated axons surrounded by a cellular element	15207
@NP	the clustering	15207
@NP	myelinated axons surrounded by a cellular element	15225
@NP	myelinated axons	15225
@NP	a cellular element	15256
@NP	D1	15276
@NP	Electron micrograph	15280
@NP	the same lesion	15305
@NP	myelinated axons surrounded by a cellular element forming a tunnel	15329
@NP	myelinated axons	15329
@NP	a cellular element forming a tunnel	15360
@NP	a cellular element	15360
@NP	a tunnel	15387
@NP	D2 , Boxed region from D1 .	15397
@NP	D2	15397
@NP	Boxed region from D1	15401
@NP	Boxed region	15401
@NP	D1	15419
@NP	Arrows	15423
@NP	the cytoplasmic region of the cell surrounding the bundle of myelinated axons	15439
@NP	the cytoplasmic region	15439
@NP	the cell surrounding the bundle of myelinated axons	15465
@NP	the cell	15465
@NP	the bundle of myelinated axons	15486
@NP	the bundle	15486
@NP	myelinated axons	15500
@NP	Scale bars : A , 0.75 mm ; B1 , B2 , 30µm ; C , 6µm ; D1 , 5µm ; D2 , 2µm .	15518
@NP	Scale bars	15518
@NP	A , 0.75 mm	15530
@NP	A	15530
@NP	0.75 mm	15533
@NP	B1 , B2 , 30µm	15542
@NP	B1	15542
@NP	B2	15546
@NP	30µm	15550
@NP	C , 6µm	15556
@NP	C	15556
@NP	6µm	15559
@NP	D1 , 5µm	15564
@NP	D1	15564
@NP	5µm	15568
@NP	D2 , 2µm	15573
@NP	D2	15573
@NP	2µm	15577
@NP	Figure 5 .	15583
@NP	Figure	15583
@NP	5	15590
@NP	FN immunostaining	15593
@NP	transverse frozen sections through the transection site 5 weeks	15614
@NP	transverse frozen sections	15614
@NP	the transection site	15649
@NP	5 weeks	15670
@NP	OEC transplantation	15684
@NP	low -LRB- A -- C -RRB- and high -LRB- D -- F -RRB- power	15707
@NP	A -- C	15713
@NP	A	15713
@NP	C	15715
@NP	D -- F	15729
@NP	D	15729
@NP	F	15731
@NP	FN	15741
@NP	the extracellualar space -LRB- E -RRB-	15760
@NP	the extracellualar space	15760
@NP	E	15787
@NP	cell membranes of some GFP-OECs -LRB- F -RRB-	15810
@NP	cell membranes	15810
@NP	some GFP-OECs -LRB- F -RRB-	15828
@NP	some GFP-OECs	15828
@NP	F	15844
@NP	P0 immunostaining	15848
@NP	the transection site	15886
@NP	close proximity to GFP donor cells	15918
@NP	close proximity	15918
@NP	GFP donor cells	15937
@NP	the red rings -LRB- arrows -RRB-	15959
@NP	the red rings	15959
@NP	arrows	15974
@NP	some	15983
@NP	green cells	16020
@NP	A -- C , Epifluorescence images ; D -- I , confocal images .	16033
@NP	A -- C , Epifluorescence images ; D	16033
@NP	C , Epifluorescence images	16035
@NP	C	16035
@NP	Epifluorescence images	16038
@NP	I , confocal images	16064
@NP	I	16064
@NP	confocal images	16067
@NP	Scale bar : -LRB- in I -RRB- A -- C , 200µm ; D -- F , 20µm ; G -- I , 10µm .	16084
@NP	Scale bar : -LRB- in I -RRB- A -- C , 200µm ; D -- F , 20µm ; G -- I , 10µm	16084
@NP	Scale bar	16084
@NP	Scale	16084
@NP	bar	16090
@NP	I	16099
@NP	A	16103
@NP	-- C , 200µm ; D -- F , 20µm ; G -- I , 10µm	16104
@NP	-- C , 200µm ; D -- F , 20µm ; G	16104
@NP	C , 200µm ; D -- F	16105
@NP	C , 200µm	16105
@NP	C	16105
@NP	200µm	16108
@NP	D -- F	16115
@NP	D	16115
@NP	F	16117
@NP	20µm ; G	16120
@NP	20µm	16120
@NP	G	16126
@NP	I , 10µm	16128
@NP	I	16128
@NP	10µm	16131
@NP	Figure 6 .	16138
@NP	Figure	16138
@NP	6	16145
@NP	Electron micrographs of anti-GFP immunoperoxidase staining of OEC transplant .	16148
@NP	Electron micrographs	16148
@NP	anti-GFP immunoperoxidase staining	16172
@NP	OEC transplant	16210
@NP	A1 , Reaction product	16226
@NP	cytoplasmic regions of the myelin-forming cell -LRB- arrows -RRB-	16262
@NP	cytoplasmic regions	16262
@NP	the myelin-forming cell -LRB- arrows -RRB-	16285
@NP	the myelin-forming cell	16285
@NP	arrows	16310
@NP	the myelin	16329
@NP	A nonlabeled myelinated axon -LRB- arrowheads -RRB-	16341
@NP	A nonlabeled myelinated axon	16341
@NP	arrowheads	16371
@NP	the labeled axon	16399
@NP	The boxed area in A1	16417
@NP	The boxed area	16417
@NP	A1	16435
@NP	A2	16450
@NP	B1 , A cross-cut section of another axon showing cytoplastic reaction product .	16454
@NP	B1	16454
@NP	A cross-cut section of another axon showing cytoplastic reaction product	16458
@NP	A cross-cut section	16458
@NP	another axon showing cytoplastic reaction product	16481
@NP	another axon	16481
@NP	cytoplastic reaction product	16502
@NP	Enlargement of the boxed area	16532
@NP	Enlargement	16532
@NP	the boxed area	16547
@NP	B2	16574
@NP	the presence of extracellular fibrous elements in B1	16583
@NP	the presence	16583
@NP	extracellular fibrous elements in B1	16599
@NP	extracellular fibrous elements	16599
@NP	B1	16633
@NP	C1 , Field showing GFP + and GFP - myelinated axons .	16637
@NP	C1	16637
@NP	Field showing GFP + and GFP - myelinated axons	16641
@NP	Field	16641
@NP	GFP + and GFP - myelinated axons	16655
@NP	GFP + and GFP	16655
@NP	GFP	16655
@NP	and GFP	16660
@NP	myelinated axons	16669
@NP	C2 , Enlargement of the boxed area in C1 .	16687
@NP	C2	16687
@NP	Enlargement of the boxed area in C1	16691
@NP	Enlargement	16691
@NP	the boxed area in C1	16706
@NP	the boxed area	16706
@NP	C1	16724
@NP	the GFP	16733
@NP	myelinated axon -LRB- arrowhead -RRB-	16742
@NP	myelinated axon	16742
@NP	arrowhead	16759
@NP	the axon associated with GFP + cytoplasmic processes that are not forming myelin	16774
@NP	the axon associated with GFP	16774
@NP	the axon	16774
@NP	GFP	16799
@NP	cytoplasmic processes that are not forming myelin	16804
@NP	cytoplasmic processes	16804
@NP	arrow	16855
@NP	D	16863
@NP	Two adjacent GFP + cells	16866
@NP	Two adjacent GFP	16866
@NP	cells	16884
@NP	one forming myelin -LRB- right -RRB-	16891
@NP	one forming myelin	16891
@NP	one	16891
@NP	one surrounding an axon without myelin formation -LRB- left -RRB-	16922
@NP	one	16922
@NP	an axon	16938
@NP	myelin formation	16954
@NP	left	16972
@NP	E , A cluster of GFP + cells associated with axons .	16979
@NP	E	16979
@NP	A cluster of GFP + cells associated with axons	16982
@NP	A cluster	16982
@NP	GFP + cells associated with axons	16995
@NP	GFP + cells	16995
@NP	axons	17022
@NP	The asterisks	17029
@NP	GFP + processes surrounding the cluster reminiscent of an A cell	17052
@NP	GFP + processes	17052
@NP	the cluster reminiscent of an A cell	17079
@NP	the cluster reminiscent	17079
@NP	an A cell	17106
@NP	Scale bars : A1 , C1 , 5µm ; A2 , C2 , D , E , 2µm ; B1 , 1µm ; B2 , 0.25 µm .	17117
@NP	Scale bars	17117
@NP	A1 , C1 , 5µm	17129
@NP	A1	17129
@NP	C1	17133
@NP	5µm	17137
@NP	A2 , C2 , D , E , 2µm	17142
@NP	A2	17142
@NP	C2	17146
@NP	D	17150
@NP	E	17153
@NP	2µm	17156
@NP	B1 , 1µm	17161
@NP	B1	17161
@NP	1µm	17165
@NP	B2 , 0.25 µm	17170
@NP	B2	17170
@NP	0.25 µm	17174
@NP	Figure 7 .	17183
@NP	Figure	17183
@NP	7	17190
@NP	Axon counts of dCST and dorsal columns -LRB- DC -RRB-	17193
@NP	Axon counts	17193
@NP	dCST and dorsal columns	17208
@NP	DC	17233
@NP	rostral and caudal	17237
@NP	the lesion for the intact -LRB- control -RRB-	17259
@NP	the lesion	17259
@NP	the intact -LRB- control -RRB-	17274
@NP	OEC transplant	17296
@NP	DMEM sham injection groups -LRB- A -RRB-	17316
@NP	DMEM sham injection groups	17316
@NP	A	17345
@NP	Counts	17349
@NP	a standardized microscopic field -LRB- 50x35µm -RRB-	17375
@NP	a standardized microscopic field	17375
@NP	50x35µm	17409
@NP	the central regions of the tracts	17421
@NP	the central regions	17421
@NP	the tracts	17444
@NP	A modest reduction in axon number	17456
@NP	A modest reduction	17456
@NP	axon number	17478
@NP	the dCST rostral	17505
@NP	the lesion in both the OEC transplants and sham injection groups	17525
@NP	the lesion	17525
@NP	both the OEC transplants and sham injection groups	17539
@NP	the OEC transplants	17544
@NP	sham injection groups	17568
@NP	The sham injection group	17591
@NP	a marked reduction in dCST axon density caudal	17620
@NP	a marked reduction	17620
@NP	dCST axon density caudal	17642
@NP	the lesion site	17670
@NP	the reduction	17691
@NP	the OEC transplants	17718
@NP	Axons in the DC	17739
@NP	Axons	17739
@NP	the DC	17748
@NP	rostral	17782
@NP	the lesion for both OEC transplant and sham injection groups	17793
@NP	the lesion	17793
@NP	both OEC transplant and sham injection groups	17808
@NP	both OEC transplant	17808
@NP	sham injection groups	17832
@NP	no difference	17859
@NP	the lesion for both groups	17896
@NP	the lesion	17896
@NP	both groups	17911
@NP	control	17937
@NP	The n values -LRB- number of animals -RRB- for each group	17946
@NP	The n values -LRB- number of animals -RRB-	17946
@NP	The n values	17946
@NP	number of animals	17960
@NP	number	17960
@NP	animals	17970
@NP	each group	17983
@NP	4 , 14 , 6 , 8 , 15 , 6 , 4 , 10 , 6 , 8 , 10 , and 6	17999
@NP	4	17999
@NP	14	18002
@NP	6	18006
@NP	8	18009
@NP	15	18012
@NP	6	18016
@NP	4	18019
@NP	10	18022
@NP	6	18026
@NP	8	18029
@NP	10	18032
@NP	6	18040
@NP	B	18076
@NP	Open-field locomotor scores	18079
@NP	OEC transplant -LRB- n = 20 -RRB- and sham injection -LRB- n = 6 -RRB-	18111
@NP	OEC transplant	18111
@NP	n	18127
@NP	20	18129
@NP	sham injection	18137
@NP	n	18153
@NP	6	18155
@NP	groups	18158
@NP	1 week	18172
@NP	5 weeks	18194
@NP	transplantation	18208
@NP	One-way ANOVA -LRB- F test significant at p 0.05 -RRB-	18225
@NP	One-way ANOVA	18225
@NP	F test	18240
@NP	p 0.05	18262
@NP	a Dunnett 's	18283
@NP	specific pairwise differences	18312
@NP	the means for the OEC transplant and the control groups	18350
@NP	the means	18350
@NP	the OEC transplant and the control groups	18364
@NP	the OEC transplant	18364
@NP	the control groups	18387
@NP	the sham control -LRB- DMEM -RRB- and control groups	18410
@NP	the sham control -LRB- DMEM -RRB-	18410
@NP	the sham control	18410
@NP	DMEM	18428
@NP	control groups	18438
@NP	The asterisks	18464
@NP	comparison between intact control animals and the experimental groups	18487
@NP	comparison	18487
@NP	intact control animals and the experimental groups	18506
@NP	intact control animals	18506
@NP	the experimental groups	18533
@NP	the pound signs	18562
@NP	the significance between the DMEM and OEC groups	18587
@NP	the significance	18587
@NP	the DMEM and OEC groups	18612
@NP	The significance levels were	18637
@NP	levels	18654
@NP	p <	18667
@NP	p	18667
@NP	<	18668
@NP	0.05	18670
@NP	p	18678
@NP	0.01 , *** p < 0.005 , and ### p < 0.005	18680
@NP	0.01	18680
@NP	*** p < 0.005 , and ### p < 0.005	18686
@NP	*** p < 0.005	18686
@NP	*** p <	18686
@NP	*** p	18686
@NP	0.005	18691
@NP	### p < 0.005	18702
@NP	### p <	18702
@NP	### p	18702
@NP	0.005	18707
@NP	All values	18714
@NP	means	18738
@NP	SEM	18745
@NP	Histology of dorsal	18751
@NP	Histology	18751
@NP	dorsal	18764
@NP	control	18784
@NP	spinal cord	18807
@NP	The extent of the dorsal funicular lesion	18819
@NP	The extent	18819
@NP	the dorsal funicular lesion	18833
@NP	1 µm plastic	18876
@NP	Azure II-stained sections	18905
@NP	Fig. 1B , B2	18932
@NP	Fig. 1B	18932
@NP	B2	18940
@NP	sham injection rats -LRB- 5 weeks after transection -RRB-	18948
@NP	sham injection rats	18948
@NP	5 weeks after transection	18969
@NP	5 weeks	18969
@NP	transection	18983
@NP	the central core of the lesion site	18997
@NP	the central core	18997
@NP	the lesion site	19017
@NP	axons	19059
@NP	phagocytic cells -LRB- Fig. 1B3 -RRB-	19081
@NP	phagocytic cells	19081
@NP	Fig. 1B3	19099
@NP	the outer margins of the lesion	19122
@NP	the outer margins	19122
@NP	the lesion	19143
@NP	small clusters of myelinated axons	19155
@NP	small clusters	19155
@NP	myelinated axons	19173
@NP	Fig. 1B5	19205
@NP	many	19220
@NP	characteristic properties	19229
@NP	i.e. , large cytoplasmic and nuclear regions surrounding the myelinated axons	19287
@NP	i.e.	19287
@NP	large cytoplasmic and nuclear regions surrounding the myelinated axons	19293
@NP	large cytoplasmic and nuclear regions	19293
@NP	the myelinated axons	19343
@NP	Rostral -LRB- 2 mm -RRB- to the lesion -LRB- Fig. 1A -RRB- , severe axon damage	19366
@NP	Rostral -LRB- 2 mm -RRB- to the lesion -LRB- Fig. 1A -RRB-	19366
@NP	Rostral -LRB- 2 mm -RRB-	19366
@NP	Rostral	19366
@NP	2 mm	19375
@NP	the lesion -LRB- Fig. 1A -RRB-	19382
@NP	the lesion	19382
@NP	Fig. 1A	19394
@NP	severe axon damage	19404
@NP	the ascending DC axons -LRB- Fig. 1A2 , A3 -RRB-	19439
@NP	the ascending DC axons	19439
@NP	Fig. 1A2 , A3	19463
@NP	Fig. 1A2	19463
@NP	A3	19472
@NP	the descending dCST axons -LRB- Fig. 1A4 , A5 -RRB-	19487
@NP	the descending dCST axons	19487
@NP	Fig. 1A4 , A5	19514
@NP	Fig. 1A4	19514
@NP	A5	19523
@NP	Caudal -LRB- 2 mm -RRB- to the lesion -LRB- Fig. 1C -RRB- , the DC axons	19528
@NP	Caudal -LRB- 2 mm -RRB- to the lesion -LRB- Fig. 1C -RRB-	19528
@NP	Caudal -LRB- 2 mm -RRB-	19528
@NP	Caudal	19528
@NP	2 mm	19536
@NP	the lesion -LRB- Fig. 1C -RRB-	19545
@NP	the lesion	19545
@NP	Fig. 1C	19557
@NP	the DC axons	19567
@NP	Fig. 1C3	19596
@NP	severe axon pathology	19611
@NP	the dCST -LRB- Fig. 1C4 , C5 -RRB-	19649
@NP	the dCST	19649
@NP	Fig. 1C4 , C5	19659
@NP	Fig. 1C4	19659
@NP	C5	19668
@NP	Some large myelinated axons	19673
@NP	the dCST caudal	19718
@NP	the lesion site as reported previously -LRB- Warden et al. , 2001 -RRB-	19737
@NP	the lesion site	19737
@NP	Warden	19777
@NP	et al. , 2001	19784
@NP	et al.	19784
@NP	2001	19792
@NP	These axons	19799
@NP	intact animals	19841
@NP	the mean cross-sectional area of these residual axons	19857
@NP	the mean cross-sectional area	19857
@NP	these residual axons	19890
@NP	0.58	19915
@NP	0.03 µm2 -LRB- n = 11 -RRB-	19922
@NP	n	19932
@NP	11	19936
@NP	0.29 x0 .01 µm2 -LRB- n = 4 -RRB- for the intact dCST	19954
@NP	0.29 x0	19954
@NP	.01 µm2 -LRB- n = 4 -RRB- for the intact dCST	19960
@NP	.01 µm2 -LRB- n = 4 -RRB-	19960
@NP	n	19968
@NP	4	19970
@NP	the intact dCST	19977
@NP	Characterization of OECs	19994
@NP	Characterization	19994
@NP	OECs	20014
@NP	cell transplantation	20025
@NP	the remaining OECs in the cell suspension	20047
@NP	the remaining OECs	20047
@NP	the cell suspension	20069
@NP	tissue culture	20119
@NP	They	20135
@NP	poly-Llysine - coated chamber slides	20174
@NP	poly-Llysine	20174
@NP	coated chamber slides	20188
@NP	day 3	20214
@NP	the predominant cell morphology	20221
@NP	spindle	20257
@NP	some flattened fibroblastlike and astrocyte-like morphologies	20282
@NP	some	20282
@NP	fibroblastlike and astrocyte-like morphologies	20297
@NP	Immunostaining coupled with Hoechst counterstaining of nuclei	20364
@NP	Immunostaining	20364
@NP	Hoechst counterstaining of nuclei	20392
@NP	Hoechst counterstaining	20392
@NP	nuclei	20419
@NP	at least 95 % of cells in 3 -- 7 d cultures	20451
@NP	at least 95 %	20451
@NP	cells in 3 -- 7 d cultures	20467
@NP	cells in 3	20467
@NP	cells	20467
@NP	3	20476
@NP	7 d cultures	20478
@NP	both p75 and S100 antigens and variable numbers	20501
@NP	p75 and S100 antigens	20506
@NP	variable numbers	20532
@NP	cells expressed GFAP -LRB- Fig. 2 -RRB-	20552
@NP	cells	20552
@NP	GFAP -LRB- Fig. 2 -RRB-	20568
@NP	GFAP	20568
@NP	Fig. 2	20574
@NP	Distribution	20583
@NP	transplanted GFPexpressing OECs	20599
@NP	the spinal cord	20638
@NP	Five weeks	20654
@NP	OEC transplantation	20671
@NP	the distribution	20692
@NP	the GFP	20712
@NP	transplanted cells	20720
@NP	sagittal frozen sections of the spinal cord	20755
@NP	sagittal frozen sections	20755
@NP	the spinal cord	20783
@NP	The cells	20800
@NP	the transection site and more	20854
@NP	the transection site	20854
@NP	more	20879
@NP	the lesion site -LRB- Fig. 3A -RRB-	20901
@NP	the lesion site	20901
@NP	Fig. 3A	20918
@NP	Higher-power micrographs -LRB- Fig. 3B -RRB-	20928
@NP	Higher-power micrographs	20928
@NP	Fig. 3B	20954
@NP	the OECs	20973
@NP	periodic bulbous regions of intense green fluorescence -LRB- Fig. 3B -RRB-	21011
@NP	periodic bulbous regions	21011
@NP	intense green fluorescence -LRB- Fig. 3B -RRB-	21039
@NP	intense green fluorescence	21039
@NP	Fig. 3B	21067
@NP	The elongated processes	21077
@NP	The	21077
@NP	processes	21091
@NP	intense fluorescence	21108
@NP	their outer margins and low fluorescence	21132
@NP	their outer margins	21132
@NP	low fluorescence	21156
@NP	the core of the process	21176
@NP	the core	21176
@NP	the process	21188
@NP	Nodal-like regions	21201
@NP	thin breaks between adjacent green cell regions -LRB- Fig. 3C , arrow -RRB-	21237
@NP	thin breaks	21237
@NP	adjacent green cell regions -LRB- Fig. 3C , arrow -RRB-	21257
@NP	adjacent green cell regions	21257
@NP	Fig. 3C , arrow	21286
@NP	Fig. 3C	21286
@NP	arrow	21295
@NP	Confocal images from sections within the lesion zone and immunostained for NF	21303
@NP	Confocal images	21303
@NP	sections	21324
@NP	the lesion zone	21340
@NP	NF	21378
@NP	red	21382
@NP	the intimate association	21396
@NP	axons with the donor GFP-expressing OECs -LRB- Fig. 3D -RRB-	21424
@NP	axons with the donor GFP-expressing OECs	21424
@NP	axons with the donor	21424
@NP	axons	21424
@NP	the donor	21435
@NP	Fig. 3D	21466
@NP	These axonal and GFP-associated clusters	21476
@NP	the center of the lesion zone that showed a paucity of axons in the sham control	21525
@NP	the center	21525
@NP	the lesion zone that showed a paucity of axons in the sham control	21539
@NP	the lesion zone	21539
@NP	a paucity of axons	21567
@NP	a paucity	21567
@NP	axons	21580
@NP	the sham control	21589
@NP	Methylene blue/Azure II semithin plastic sections	21607
@NP	this region of the lesion 5 weeks after transplantation	21665
@NP	this region	21665
@NP	the lesion 5 weeks after transplantation	21680
@NP	the lesion	21680
@NP	5 weeks	21691
@NP	transplantation	21705
@NP	greater structural detail	21730
@NP	Li	21782
@NP	et al. -LRB- 1997 -RRB-	21785
@NP	et al.	21785
@NP	1997	21793
@NP	small groups of myelinated axons	21800
@NP	small groups	21800
@NP	myelinated axons	21816
@NP	a nonmyelinating cell forming tube-like structures around the myelinated axons	21858
@NP	a nonmyelinating cell	21858
@NP	tube-like structures	21888
@NP	the myelinated axons	21916
@NP	This organization	21938
@NP	endogenous repair	21978
@NP	transplantation of SCs -LRB- Imaizumi et al. , 2000a -RRB-	22005
@NP	transplantation	22005
@NP	SCs -LRB- Imaizumi et al. , 2000a -RRB-	22024
@NP	SCs	22024
@NP	Imaizumi	22029
@NP	et al. , 2000a	22038
@NP	et al.	22038
@NP	2000a	22046
@NP	These profiles	22054
@NP	both dorsal -LRB- Fig. 4A , B1 -RRB-	22086
@NP	both dorsal	22086
@NP	Fig. 4A , B1	22099
@NP	Fig. 4A	22099
@NP	B1	22107
@NP	ventral -LRB- Fig. 4A , B2 -RRB- regions of the lesion zone	22115
@NP	ventral -LRB- Fig. 4A , B2 -RRB- regions	22115
@NP	Fig. 4A , B2	22124
@NP	the lesion zone	22147
@NP	Electron micrographs	22164
@NP	the myelinated axons in the lesion zone	22207
@NP	the myelinated axons	22207
@NP	the lesion zone	22231
@NP	cytoplasmic extensions of cells forming tunnels -LRB- Fig. 4D1 , D2 -RRB-	22265
@NP	cytoplasmic extensions	22265
@NP	cells forming tunnels -LRB- Fig. 4D1 , D2 -RRB-	22291
@NP	cells	22291
@NP	tunnels -LRB- Fig. 4D1 , D2 -RRB-	22305
@NP	tunnels	22305
@NP	Fig. 4D1 , D2	22314
@NP	Fig. 4D1	22314
@NP	D2	22323
@NP	These clusters of myelinated axons	22328
@NP	These clusters	22328
@NP	myelinated axons	22346
@NP	animal	22382
@NP	animal	22392
@NP	the lesion zone	22431
@NP	FN immunoreactivity	22448
@NP	the central core	22492
@NP	the lesion where GFP-expressing OECs were present -LRB- Fig. 5A -- F -RRB-	22512
@NP	the lesion	22512
@NP	GFP-expressing OECs	22529
@NP	Fig. 5A -- F	22563
@NP	Fig. 5A	22563
@NP	F	22571
@NP	FN	22575
@NP	an apparent extracellular localization -LRB- Fig. 5E -RRB-	22582
@NP	an apparent extracellular localization	22582
@NP	Fig. 5E	22622
@NP	some association with GFPexpressing donor cells -LRB- Fig. 5F -RRB-	22642
@NP	some association	22642
@NP	GFPexpressing donor cells -LRB- Fig. 5F -RRB-	22664
@NP	GFPexpressing donor cells	22664
@NP	Fig. 5F	22691
@NP	Rings of P0 labeling	22701
@NP	Rings	22701
@NP	P0 labeling	22710
@NP	some regions of the lesion	22739
@NP	some regions	22739
@NP	the lesion	22755
@NP	GFP cellular elements -LRB- Fig. 5G -- I -RRB-	22797
@NP	GFP cellular elements	22797
@NP	Fig. 5G -- I	22820
@NP	Fig. 5G	22820
@NP	I	22828
@NP	two transplanted animals from which P0 immunostaining was performed	22835
@NP	two transplanted animals	22835
@NP	P0 immunostaining	22871
@NP	axons	22904
@NP	a section in the center of the lesion	22928
@NP	a section	22928
@NP	the center of the lesion	22941
@NP	the center	22941
@NP	the lesion	22955
@NP	the number of GFP + profiles that were associated with P0 rings	22978
@NP	the number	22978
@NP	GFP + profiles that were associated with P0 rings	22992
@NP	GFP + profiles	22992
@NP	P0 rings	23032
@NP	the 81 P0 identified rings	23045
@NP	the 81 P0	23045
@NP	rings	23066
@NP	34 -LRB- 42 % -RRB-	23073
@NP	34	23073
@NP	42 %	23077
@NP	GFP + profiles	23103
@NP	GFP	23103
@NP	profiles	23108
@NP	42 -LRB- 52 % -RRB-	23118
@NP	42	23118
@NP	52 %	23122
@NP	5 -LRB- 6 % -RRB-	23141
@NP	5	23141
@NP	6 %	23144
@NP	Immuno-electron microscopy	23173
@NP	GFP-expressing OECs	23203
@NP	myelin Electron	23231
@NP	microscopic -LRB- EM -RRB- examination of anti-GFP immunoperoxidase	23247
@NP	microscopic -LRB- EM -RRB- examination	23247
@NP	EM	23260
@NP	anti-GFP immunoperoxidase	23279
@NP	sections	23314
@NP	many detectable GFP cells	23337
@NP	direct contact with host axons	23372
@NP	direct contact	23372
@NP	host axons	23392
@NP	Reaction product	23404
@NP	the cytoplasm	23444
@NP	many cells	23461
@NP	multi-laminate structures characteristic of myelin -LRB- Fig. 6 -RRB-	23497
@NP	multi-laminate structures	23497
@NP	Fig. 6	23549
@NP	a longitudinal section of a myelinated axon	23561
@NP	a longitudinal section	23561
@NP	a myelinated axon	23587
@NP	intense reaction product	23606
@NP	the cytoplasm of the myelin-forming cell -LRB- Fig. 6A1 , A2 ; arrows -RRB-	23646
@NP	the cytoplasm	23646
@NP	the myelin-forming cell -LRB- Fig. 6A1 , A2 ; arrows -RRB-	23663
@NP	the myelin-forming cell	23663
@NP	Fig. 6A1 , A2 ; arrows	23688
@NP	Fig. 6A1	23688
@NP	A2 ; arrows	23697
@NP	A2	23697
@NP	arrows	23701
@NP	Large cytoplasmic and nuclear regions -LRB- Fig. 6A1 -RRB-	23710
@NP	Large cytoplasmic and nuclear regions	23710
@NP	Fig. 6A1	23749
@NP	the presence of basal lamina and extracellular fibrils -LRB- Fig. 6B1 -RRB-	23767
@NP	the presence	23767
@NP	basal lamina and extracellular fibrils -LRB- Fig. 6B1 -RRB-	23783
@NP	basal lamina and extracellular fibrils	23783
@NP	Fig. 6B1	23823
@NP	a peripheral pattern of myelination	23842
@NP	a peripheral pattern	23842
@NP	myelination	23866
@NP	Some unlabeled cells forming peripheral-like myelin	23879
@NP	Some unlabeled cells	23879
@NP	peripheral-like	23908
@NP	transplanted lesions	23961
@NP	the same areas	23985
@NP	the labeled cells -LRB- Fig. 6A1 , A2 , C1 , C2 ; arrowheads -RRB-	24003
@NP	the labeled cells	24003
@NP	Fig. 6A1 , A2 , C1	24022
@NP	Fig. 6A1	24022
@NP	A2	24031
@NP	C1	24034
@NP	C2 ; arrowheads	24037
@NP	C2	24037
@NP	arrowheads	24041
@NP	A limited number of GFP + cells	24054
@NP	A limited number	24054
@NP	GFP + cells	24074
@NP	GFP	24074
@NP	cells	24079
@NP	host axons	24096
@NP	myelin -LRB- Fig. 6D -RRB-	24124
@NP	myelin	24124
@NP	Fig. 6D	24132
@NP	We	24142
@NP	a first approximation of the relative contribution of donor cell	24168
@NP	a first approximation	24168
@NP	the relative contribution of donor cell	24193
@NP	the relative contribution	24193
@NP	donor cell	24222
@NP	host cell myelination	24236
@NP	the number of GFP	24270
@NP	the number	24270
@NP	GFP	24284
@NP	+	24287
@NP	myelinated axon profiles	24298
@NP	a region	24326
@NP	an OEC transplanted lesion	24338
@NP	a relatively large number of myelinated axons	24374
@NP	a relatively large number	24374
@NP	myelinated axons	24403
@NP	Extensive quantification with this method	24421
@NP	Extensive quantification	24421
@NP	this method	24451
@NP	the technical difficulties associated with the method -LRB- see Discussion -RRB-	24491
@NP	the technical difficulties	24491
@NP	the method -LRB- see Discussion -RRB-	24534
@NP	the method	24534
@NP	Discussion	24550
@NP	counts	24572
@NP	the lesion center of a single transplant animal	24598
@NP	the lesion center	24598
@NP	a single transplant animal	24619
@NP	the 193 axons in this region	24650
@NP	the 193 axons	24650
@NP	this region	24667
@NP	we	24680
@NP	a total of 131 GFP + cells	24694
@NP	a total	24694
@NP	131 GFP + cells	24705
@NP	131 GFP	24705
@NP	cells	24714
@NP	these GFP + cells	24724
@NP	these GFP	24724
@NP	cells	24735
@NP	two -LRB- slightly < 2 % -RRB-	24742
@NP	two	24742
@NP	slightly < 2 %	24747
@NP	slightly <	24747
@NP	2 %	24757
@NP	no direct contact	24768
@NP	axons	24791
@NP	The myelin-forming status of 18 GFP + cells -LRB- 14 % -RRB-	24798
@NP	The myelin-forming status	24798
@NP	18 GFP + cells -LRB- 14 % -RRB-	24827
@NP	18 GFP	24827
@NP	cells	24835
@NP	14 %	24842
@NP	poor membrane preservation	24882
@NP	the 118 GFP + cells with a status that could be identified	24913
@NP	the 118 GFP	24913
@NP	cells with a status that could be identified	24926
@NP	cells	24926
@NP	a status that could be identified	24937
@NP	a status	24937
@NP	74 cells -LRB- 57 % -RRB-	24972
@NP	74 cells	24972
@NP	57 %	24982
@NP	distinct myelin structure	24994
@NP	The	25021
@NP	maining 37	25029
@NP	GFP + cells -LRB- 28 % -RRB-	25040
@NP	GFP + cells	25040
@NP	28 %	25052
@NP	varying stages of wrapping or engulfing the axons	25075
@NP	varying stages	25075
@NP	the axons	25115
@NP	distinct compact	25142
@NP	this same region	25174
@NP	62 myelinated axon profiles	25192
@NP	they	25243
@NP	myelin-forming cells that did not contain DAB reaction product	25264
@NP	myelin-forming cells	25264
@NP	DAB reaction product	25306
@NP	the 136 axons that displayed compact myelin	25337
@NP	the 136 axons	25337
@NP	compact	25366
@NP	54 %	25382
@NP	GFP + and 46 % were GFP	25391
@NP	GFP	25391
@NP	and 46 % were GFP	25396
@NP	and 46 %	25396
@NP	These data	25415
@NP	general agreement with the P0	25433
@NP	general agreement	25433
@NP	the P0	25456
@NP	immunostaining data	25463
@NP	approximately half of the myelin profiles	25492
@NP	approximately half	25492
@NP	the myelin profiles	25514
@NP	GFP	25539
@NP	+	25542
@NP	Morphometric analysis	25545
@NP	the lesion center	25570
@NP	a very small number of myelinated axons	25589
@NP	a very small number	25589
@NP	myelinated axons	25612
@NP	the sham injection group -LRB- 64 ± 32 ; n = 7 -RRB-	25645
@NP	the sham injection group	25645
@NP	64 ± 32 ; n = 7	25671
@NP	64	25671
@NP	± 32 ; n = 7	25674
@NP	± 32	25674
@NP	n = 7	25680
@NP	n	25680
@NP	7	25684
@NP	more myelinated axons	25692
@NP	the OEC transplant group -LRB- 244 ± 50 ; n = 5 -RRB-	25731
@NP	the OEC transplant group	25731
@NP	244 ± 50 ; n = 5	25757
@NP	244	25757
@NP	± 50 ; n = 5	25760
@NP	± 50	25760
@NP	n = 5	25765
@NP	n	25765
@NP	5	25767
@NP	Axons	25771
@NP	single sections	25795
@NP	the specified regions	25814
@NP	multiple animals -LRB- n -RRB-	25853
@NP	multiple animals	25853
@NP	n	25871
@NP	Axon counts	25893
@NP	central regions of the DC and the dCST	25935
@NP	central regions	25935
@NP	the DC and the dCST	25954
@NP	the DC	25954
@NP	the dCST	25965
@NP	2 mm rostral and 2 mm caudal	25977
@NP	2 mm rostral	25977
@NP	2 mm caudal	25994
@NP	the lesion	26009
@NP	both the sham injection and OEC transplant groups	26024
@NP	the sham injection	26029
@NP	OEC transplant groups	26052
@NP	there	26075
@NP	extensive axon loss in the DC rostral	26085
@NP	extensive axon loss	26085
@NP	the DC rostral	26108
@NP	the lesion , but not caudal -LRB- Fig. 7A -RRB-	26126
@NP	the lesion	26126
@NP	caudal -LRB- Fig. 7A -RRB-	26146
@NP	caudal	26146
@NP	Fig. 7A	26154
@NP	A modest reduction in axons	26164
@NP	A modest reduction	26164
@NP	axons	26186
@NP	the dCST rostral	26208
@NP	the lesion for both the sham injection and OEC transplant groups	26228
@NP	the lesion	26228
@NP	both the sham injection and OEC transplant groups	26243
@NP	the sham injection	26248
@NP	OEC transplant groups	26271
@NP	the axon number	26303
@NP	the dCST caudal	26347
@NP	the lesion in the OEC transplant group -LRB- Fig. 7A -RRB-	26366
@NP	the lesion	26366
@NP	the OEC transplant group -LRB- Fig. 7A -RRB-	26380
@NP	the OEC transplant group	26380
@NP	Fig. 7A	26406
@NP	These observations	26416
@NP	expected anterograde degeneration of distal cut axons	26455
@NP	expected anterograde degeneration	26455
@NP	distal cut axons	26492
@NP	some retrograde degeneration.OECtransplants	26513
@NP	greater numbers of axons in the dCST	26564
@NP	greater numbers	26564
@NP	axons in the dCST	26583
@NP	axons	26583
@NP	the dCST	26592
@NP	2 mm caudal	26604
@NP	the lesion	26619
@NP	axon counts	26642
@NP	a standardized 50 x 36 µm field	26668
@NP	a standardized 50	26668
@NP	36 µm field	26688
@NP	the central region of the dCST , 2.0 mm caudal to the lesion ,	26703
@NP	the central region	26703
@NP	the dCST , 2.0 mm caudal to the lesion ,	26725
@NP	the dCST	26725
@NP	2.0 mm caudal to the lesion	26735
@NP	2.0 mm caudal	26735
@NP	the lesion	26752
@NP	an increase in axon number from 145	26774
@NP	an increase	26774
@NP	axon number from 145	26789
@NP	axon number	26789
@NP	145	26806
@NP	16 -LRB- n = 6 -RRB- in the sham injection group	26812
@NP	16 -LRB- n = 6 -RRB-	26812
@NP	16	26812
@NP	n	26816
@NP	6	26820
@NP	the sham injection group	26826
@NP	338 ±	26854
@NP	48 -LRB- n = 15 -RRB-	26858
@NP	48	26858
@NP	n	26862
@NP	15	26864
@NP	the OEC transplant group -LRB- p < 0.005 -RRB-	26871
@NP	the OEC transplant group	26871
@NP	p < 0.005	26898
@NP	p	26898
@NP	< 0.005	26900
@NP	<	26900
@NP	0.005	26902
@NP	878 x 16 -LRB- n = 8 -RRB- in normal -LRB- intact -RRB- rats	26923
@NP	878	26923
@NP	16 -LRB- n = 8 -RRB- in normal -LRB- intact -RRB- rats	26929
@NP	16 -LRB- n = 8 -RRB-	26929
@NP	16	26929
@NP	n	26933
@NP	8	26937
@NP	normal -LRB- intact -RRB- rats	26943
@NP	hindlimb locomotor function	26974
@NP	All animals	27002
@NP	a gradual improvement	27024
@NP	hindlimb locomotor function	27049
@NP	the 5 week recovery period -LRB- Fig. 7B -RRB-	27084
@NP	the 5 week recovery period	27084
@NP	Fig. 7B	27112
@NP	The sham injection group	27122
@NP	a BBB score of ≈ 9	27160
@NP	a BBB score	27160
@NP	≈ 9	27175
@NP	weight-bearing plantar stepping	27199
@NP	weight-bearing plantar	27199
@NP	the OEC transplant group	27241
@NP	18	27280
@NP	the BBB score	27286
@NP	consistent weight-bearing plantar stepping	27314
@NP	consistent weight-bearing plantar	27314
@NP	Statistical analysis	27358
@NP	the open-field locomotor scores at 3	27394
@NP	the open-field locomotor scores	27394
@NP	3	27429
@NP	4	27432
@NP	5 weeks after injury and OEC transplantation	27439
@NP	5 weeks	27439
@NP	injury and OEC transplantation	27453
@NP	sham injection	27514
@NP	Discussion A large body of work	27531
@NP	Discussion A large body	27531
@NP	Discussion A	27531
@NP	work	27558
@NP	the proposal	27572
@NP	transplantation of OECs into various spinal cord injury and demyelination models	27590
@NP	transplantation	27590
@NP	OECs into various spinal cord injury and demyelination models	27609
@NP	OECs	27609
@NP	various spinal cord injury and demyelination models	27619
@NP	axonal regeneration , remyelination , and functional recovery	27683
@NP	axonal regeneration	27683
@NP	remyelination	27704
@NP	functional recovery	27723
@NP	Franklin	27744
@NP	et al. , 1996	27753
@NP	et al.	27753
@NP	1996	27761
@NP	Li et al. , 1997 , 1998	27767
@NP	Li	27767
@NP	et al. , 1997 , 1998	27770
@NP	et al.	27770
@NP	1997	27778
@NP	1998	27784
@NP	Ramon-Cueto et al. , 1998 , 2000	27790
@NP	Ramon-Cueto	27790
@NP	et al. , 1998 , 2000	27802
@NP	et al.	27802
@NP	1998	27810
@NP	2000	27816
@NP	Imaizumi et al. , 2000a , b	27822
@NP	Imaizumi	27822
@NP	et al. , 2000a , b	27831
@NP	et al.	27831
@NP	2000a	27839
@NP	b	27845
@NP	Lu et al. , 2002	27848
@NP	Lu	27848
@NP	et al. , 2002	27851
@NP	et al.	27851
@NP	2002	27859
@NP	Keyvan-Fouladi et al. , 2003	27865
@NP	Keyvan-Fouladi	27865
@NP	et al. , 2003	27880
@NP	et al.	27880
@NP	2003	27888
@NP	Plant et al. , 2003	27894
@NP	Plant	27894
@NP	et al. , 2003	27900
@NP	et al.	27900
@NP	2003	27908
@NP	there	27920
@NP	an important controversy	27929
@NP	the transplanted OECs	27968
@NP	axons	28005
@NP	peripheral	28020
@NP	they	28049
@NP	endogenous SCs that form myelin	28062
@NP	endogenous SCs	28062
@NP	Takami	28095
@NP	et al. , 2002 ; Boyd et al. , 2004	28102
@NP	et al.	28102
@NP	2002 ; Boyd et al.	28110
@NP	2002	28110
@NP	Boyd et al.	28116
@NP	Boyd	28116
@NP	et al.	28121
@NP	2004	28129
@NP	OECs	28136
@NP	a number	28153
@NP	trophic factors , transcription factors , and extracellular matrix molecules	28165
@NP	trophic factors	28165
@NP	transcription factors	28182
@NP	extracellular matrix molecules	28209
@NP	Ramon-Cueto and Avila	28241
@NP	Ramon-Cueto	28241
@NP	Avila	28257
@NP	1998 ; Chuah and West , 2002 ; Au and Roskams , 2003 ; Ramer et al. , 2004	28264
@NP	1998	28264
@NP	Chuah and West , 2002 ; Au and Roskams , 2003 ; Ramer et al. , 2004	28270
@NP	Chuah and West , 2002	28270
@NP	Chuah and West	28270
@NP	2002	28286
@NP	Au and Roskams , 2003	28292
@NP	Au and Roskams	28292
@NP	2003	28308
@NP	Ramer et al. , 2004	28314
@NP	Ramer	28314
@NP	et al. , 2004	28320
@NP	et al.	28320
@NP	2004	28328
@NP	endogenous SC cell invasion , angiogenesis , and activation of progenitor cells	28356
@NP	endogenous SC cell invasion	28356
@NP	angiogenesis	28385
@NP	activation of progenitor cells	28403
@NP	activation	28403
@NP	progenitor cells	28417
@NP	repair	28448
@NP	It	28456
@NP	some degree of SC invasion associated with axonal repair	28473
@NP	some degree	28473
@NP	SC invasion associated with axonal repair	28488
@NP	SC invasion	28488
@NP	axonal repair	28516
@NP	enhancement of this process	28545
@NP	enhancement	28545
@NP	this process	28560
@NP	functional recovery	28590
@NP	the present study	28614
@NP	we	28633
@NP	transplanted GFP-expressing OECs	28648
@NP	adult rat	28694
@NP	olfactory bulb	28704
@NP	at least 5 weeks -LRB- study period -RRB-	28731
@NP	at least 5 weeks	28731
@NP	study period	28749
@NP	the lesion zone	28770
@NP	axons spanning the lesion	28817
@NP	axons	28817
@NP	the lesion	28832
@NP	an ultrastructural level	28851
@NP	myelin-forming cells	28896
@NP	These findings	28918
@NP	the possibility	28947
@NP	endogenous SC invasion	28968
@NP	the OEC grafts	29009
@NP	the donor OECs	29049
@NP	we	29103
@NP	GFP - cells that were associated with myelinated axons in the lesion zone	29117
@NP	GFP	29117
@NP	cells that were associated with myelinated axons in the lesion zone	29122
@NP	cells	29122
@NP	myelinated axons in the lesion zone	29154
@NP	myelinated axons	29154
@NP	the lesion zone	29174
@NP	Other supportive evidence for the myelinating potential of the OECs	29191
@NP	Other supportive evidence	29191
@NP	the myelinating potential of the OECs	29221
@NP	the myelinating potential	29221
@NP	the OECs	29250
@NP	studies	29275
@NP	the X-irradiation	29289
@NP	ethidium bromide -LRB- X-EB -RRB- model	29308
@NP	ethidium bromide -LRB- X-EB -RRB-	29308
@NP	ethidium bromide	29308
@NP	X-EB	29326
@NP	persistent demyelination in the spinal cord	29341
@NP	persistent demyelination	29341
@NP	the spinal cord	29369
@NP	Franklin	29386
@NP	et al. , 1996	29395
@NP	et al.	29395
@NP	1996	29403
@NP	Imaizumi et al. , 1998	29409
@NP	Imaizumi	29409
@NP	et al. , 1998	29418
@NP	et al.	29418
@NP	1998	29426
@NP	Barnett et al. , 2000	29432
@NP	Barnett	29432
@NP	et al. , 2000	29440
@NP	et al.	29440
@NP	2000	29448
@NP	Kato et al. , 2000	29454
@NP	Kato	29454
@NP	et al. , 2000	29459
@NP	et al.	29459
@NP	2000	29467
@NP	Akiyama et al. , 2004	29473
@NP	Akiyama	29473
@NP	et al. , 2004	29481
@NP	et al.	29481
@NP	2004	29489
@NP	the transection model used in the present study	29499
@NP	the transection model	29499
@NP	the present study	29529
@NP	the lesions	29548
@NP	axon profiles through the lesion zone	29582
@NP	axon profiles	29582
@NP	the lesion zone	29604
@NP	less numerous than in the demyelinating X-EB lesion	29625
@NP	less numerous	29625
@NP	the demyelinating X-EB lesion	29647
@NP	GFP + myelinating profiles	29687
@NP	GFP	29687
@NP	myelinating profiles	29692
@NP	NF	29766
@NP	axons	29780
@NP	a light microcopic level and GFP immunoreactivity on an ultrastructural level	29789
@NP	a light microcopic level and GFP immunoreactivity	29789
@NP	an ultrastructural level	29842
@NP	A unique feature of presumptive axonal regeneration after OEC transplantation	29868
@NP	A unique feature	29868
@NP	presumptive axonal regeneration after OEC transplantation	29888
@NP	presumptive axonal regeneration	29888
@NP	OEC transplantation	29926
@NP	the occurrence	29949
@NP	groups	29967
@NP	axons	29977
@NP	the transection lesion site	29990
@NP	a peripheral pattern	30023
@NP	myelination	30047
@NP	a fibroblast-like cell	30073
@NP	a `` tunnel ''	30107
@NP	small clusters of myelinated axons -LRB- Li et al. , 1997 -RRB-	30125
@NP	small clusters	30125
@NP	myelinated axons -LRB- Li et al. , 1997 -RRB-	30143
@NP	myelinated axons	30143
@NP	Li	30161
@NP	et al. , 1997	30164
@NP	et al.	30164
@NP	1997	30172
@NP	These tunnels	30179
@NP	SC transplantation	30222
@NP	transection lesions -LRB- Imaizumi et al. , 2000a , b -RRB-	30246
@NP	transection lesions	30246
@NP	Imaizumi	30267
@NP	et al. , 2000a , b	30276
@NP	et al.	30276
@NP	2000a	30284
@NP	b	30290
@NP	demyelinating lesions -LRB- Lankford et al. , 2002 -RRB-	30301
@NP	demyelinating lesions	30301
@NP	Lankford	30324
@NP	et al. , 2002	30333
@NP	et al.	30333
@NP	2002	30341
@NP	Li et al. -LRB- 1998 -RRB-	30348
@NP	Li et al.	30348
@NP	Li	30348
@NP	et al.	30351
@NP	1998	30359
@NP	the surrounding fibroblast-like cells	30377
@NP	`` A '' cells and the myelin-forming cells as `` S '' cells	30418
@NP	`` A '' cells	30418
@NP	the myelin-forming cells as `` S '' cells	30432
@NP	the myelin-forming cells	30432
@NP	`` S '' cells	30460
@NP	both	30489
@NP	the donor OECs	30514
@NP	transplanted SCs	30538
@NP	spinal cord axons	30569
@NP	Blakemore and Crang	30588
@NP	1985 ; Baron-Van Evercooren et al. , 1992 ; Honmou et al.	30609
@NP	1985	30609
@NP	Baron-Van Evercooren et al. , 1992 ; Honmou et al.	30615
@NP	Baron-Van Evercooren	30615
@NP	et al. , 1992 ; Honmou et al.	30636
@NP	et al. , 1992	30636
@NP	et al.	30636
@NP	1992	30644
@NP	Honmou et al.	30650
@NP	Honmou	30650
@NP	et al.	30657
@NP	1996	30665
@NP	improved functional outcome -LRB- Takami et al. , 2002 -RRB-	30695
@NP	improved functional outcome	30695
@NP	Takami	30724
@NP	et al. , 2002	30731
@NP	et al.	30731
@NP	2002	30739
@NP	the A and S cell organization	30746
@NP	OEC transplantation	30800
@NP	Li et al. , 1997 , 1998 ; Imaizumi et al. , 2000a , b	30821
@NP	Li et al.	30821
@NP	Li	30821
@NP	et al.	30824
@NP	1997 , 1998 ; Imaizumi et al.	30832
@NP	1997 , 1998	30832
@NP	1997	30832
@NP	1998	30838
@NP	Imaizumi et al.	30844
@NP	Imaizumi	30844
@NP	et al.	30853
@NP	2000a , b	30861
@NP	2000a	30861
@NP	b	30867
@NP	Boyd et al. -LRB- 2004 -RRB-	30880
@NP	Boyd et al.	30880
@NP	Boyd	30880
@NP	et al.	30885
@NP	2004	30893
@NP	LacZ-expressing S cells	30912
@NP	transplantation	30942
@NP	embryonic day 18-derived OECs	30961
@NP	a spinal cord compression injury model	30996
@NP	LacZ-expressing fibroblast-like cells	31044
@NP	They	31083
@NP	only the fibroblast-like cell	31103
@NP	the OEC transplantation	31149
@NP	the S cells	31182
@NP	SCs	31232
@NP	Wefound clear qualitative evidence	31237
@NP	GFP immunoreactivity	31275
@NP	an ultrastructural level	31299
@NP	the cytoplasm	31327
@NP	cells	31344
@NP	the lesion site that were forming peripheral-like myelin	31357
@NP	the lesion site	31357
@NP	peripheral-like	31391
@NP	Staining of intracellular antigens for EM analysis	31415
@NP	Staining	31415
@NP	intracellular antigens for EM analysis	31427
@NP	intracellular antigens	31427
@NP	EM analysis	31454
@NP	a compromise between structural preservation and antibody penetration	31475
@NP	a compromise	31475
@NP	structural preservation and antibody penetration	31496
@NP	the amount of usable samples with this method	31550
@NP	the amount	31550
@NP	usable samples with this method	31564
@NP	usable samples	31564
@NP	this method	31584
@NP	an area in which numerous myelin profiles were observed on an EM level	31620
@NP	an area	31620
@NP	numerous myelin profiles	31637
@NP	an EM level	31679
@NP	there	31692
@NP	a relatively high proportion	31702
@NP	DABpositive cells	31734
@NP	myelinated axon profiles	31768
@NP	half of the myelinated profiles	31799
@NP	half	31799
@NP	the myelinated profiles	31807
@NP	GFP + cells	31852
@NP	GFP	31852
@NP	cells	31857
@NP	It	31864
@NP	some myelin-forming cells that did not contain DAB reaction product	31884
@NP	some myelin-forming cells	31884
@NP	DAB reaction product	31931
@NP	fact , false negatives	31961
@NP	fact	31961
@NP	false negatives	31967
@NP	incomplete permeablization and poor penetration of antibodies	31993
@NP	incomplete permeablization and poor penetration	31993
@NP	antibodies	32044
@NP	it	32060
@NP	both host and donor cells	32081
@NP	host	32086
@NP	donor cells	32095
@NP	myelination of lesioned axons	32135
@NP	myelination	32135
@NP	lesioned axons	32150
@NP	These data	32166
@NP	transplantation	32191
@NP	adult OECs	32210
@NP	relatively high purity -LRB- > 95 % p75 + -RRB-	32233
@NP	relatively high purity	32233
@NP	> 95 % p75	32257
@NP	>	32257
@NP	95 % p75	32258
@NP	+	32265
@NP	culture for extensive periods	32290
@NP	culture	32290
@NP	extensive periods	32302
@NP	peripheral-like	32337
@NP	axons	32367
@NP	a dorsal funiculus transection	32382
@NP	Boyd et al. -LRB- 2004 -RRB-	32414
@NP	Boyd et al.	32414
@NP	Boyd	32414
@NP	et al.	32419
@NP	2004	32427
@NP	the possibility	32440
@NP	failure of the fetalderived OECs to myelinate axons in vivo	32461
@NP	failure	32461
@NP	the fetalderived OECs to myelinate axons in vivo	32472
@NP	the fetalderived OECs	32472
@NP	myelinate axons in vivo	32497
@NP	myelinate axons	32497
@NP	vivo	32516
@NP	LacZ expression	32537
@NP	its protein product betta-galactosidase	32557
@NP	myelin synthesis	32615
@NP	they	32642
@NP	this possibility	32662
@NP	There	32680
@NP	questions	32700
@NP	efficiency of transfection and stability of the transfection procedure	32713
@NP	efficiency	32713
@NP	transfection and stability of the transfection procedure	32727
@NP	transfection and stability	32727
@NP	the transfection procedure	32757
@NP	detection	32801
@NP	GFP expression in the cells used in the present study	32812
@NP	GFP expression	32812
@NP	the cells used in the present study	32830
@NP	the cells	32830
@NP	the present study	32848
@NP	the cytoplasm of these cells	32902
@NP	the cytoplasm	32902
@NP	these cells	32919
@NP	A difficulty	32932
@NP	results	32958
@NP	OEC transplantation studies	32971
@NP	various laboratories	33004
@NP	differences	33033
@NP	the age	33060
@NP	the animals	33071
@NP	cell harvesting , purification procedures , and lesion models	33092
@NP	cell harvesting	33092
@NP	purification procedures	33109
@NP	lesion models	33138
@NP	the cells	33163
@NP	OECs used in the present study	33192
@NP	OECs	33192
@NP	the present study	33205
@NP	the outer nerve layer	33261
@NP	the adult olfactory bulb	33286
@NP	an area rich in OECs in vivo -LRB- Devon and Doucette , 1992 -RRB-	33312
@NP	an area rich in OECs in vivo	33312
@NP	an area	33312
@NP	OECs in vivo	33328
@NP	OECs	33328
@NP	vivo	33336
@NP	Devon and Doucette	33342
@NP	1992	33362
@NP	The degree	33369
@NP	cell purity	33383
@NP	> 95 %	33396
@NP	>	33396
@NP	95 %	33397
@NP	our cell suspension as assessed using p75/S100 immunostaining	33405
@NP	our cell suspension	33405
@NP	p75/S100 immunostaining	33443
@NP	other studies	33492
@NP	immunopanning techniques	33515
@NP	Takami	33551
@NP	et al. , 2002 ; Lakatos et al. , 2003	33558
@NP	et al.	33558
@NP	2002 ; Lakatos et al.	33566
@NP	2002	33566
@NP	Lakatos et al.	33572
@NP	Lakatos	33572
@NP	et al.	33580
@NP	2003	33588
@NP	OECs	33606
@NP	embryonic	33630
@NP	Devon and Doucette	33648
@NP	1992	33668
@NP	Mitotic inhibitors and stimulators of cell proliferation and differentiation	33675
@NP	Mitotic inhibitors and stimulators	33675
@NP	cell proliferation and differentiation	33713
@NP	those studies	33765
@NP	our cell preparation method from adult tissue	33783
@NP	our cell preparation method	33783
@NP	adult tissue	33816
@NP	we	33830
@NP	mitotic inhibitors	33845
@NP	we	33873
@NP	proliferation and differentiation in vivo	33886
@NP	proliferation and differentiation	33886
@NP	vivo	33923
@NP	Contamination by SCs , which are also p75/S100 positive , in our cultures	33929
@NP	Contamination	33929
@NP	SCs , which are also p75/S100 positive , in our cultures	33946
@NP	SCs	33946
@NP	p75/S100	33966
@NP	our cultures	33988
@NP	the interpretation that adult OECs are able to form peripherallike myelin	34025
@NP	the interpretation that adult OECs are able to form	34025
@NP	the interpretation	34025
@NP	adult OECs	34049
@NP	one	34109
@NP	a very minor contamination of SCs	34136
@NP	a very minor contamination	34136
@NP	SCs	34166
@NP	blood vessel innervation	34195
@NP	Takami	34221
@NP	et al. , 2002	34228
@NP	et al.	34228
@NP	2002	34236
@NP	meningeal cells	34245
@NP	Lakatos	34262
@NP	et al. , 2003	34270
@NP	et al.	34270
@NP	2003	34278
@NP	Such minor contamination	34285
@NP	the vast majority -LRB- > 95 % -RRB- of our cells	34332
@NP	the vast majority -LRB- > 95 % -RRB-	34332
@NP	the vast majority	34332
@NP	> 95 %	34351
@NP	>	34351
@NP	95 %	34352
@NP	our cells	34360
@NP	a p75/S100 phenotype	34381
@NP	the present study	34406
@NP	we	34425
@NP	myelination of axons and the distribution of donor cells	34439
@NP	myelination of axons	34439
@NP	myelination	34439
@NP	axons	34454
@NP	the distribution of donor cells	34464
@NP	the distribution	34464
@NP	donor cells	34484
@NP	axonal regeneration	34507
@NP	we	34544
@NP	the dorsal funiculus	34580
@NP	there	34602
@NP	the prospect	34611
@NP	some residual axons	34629
@NP	GFP donor cells	34665
@NP	the lesion zone	34702
@NP	variable degrees outside of the transection zone	34731
@NP	variable degrees	34731
@NP	the transection zone	34759
@NP	much of the cellular matrix within the `` repair '' zone	34787
@NP	much	34787
@NP	the cellular matrix within the `` repair '' zone	34795
@NP	the cellular matrix	34795
@NP	the `` repair '' zone	34822
@NP	donor cells	34857
@NP	GFP	34870
@NP	NF staining	34898
@NP	cells that associated with axons	34937
@NP	cells	34937
@NP	axons	34964
@NP	This	34971
@NP	the hypothesis	34985
@NP	Li	35001
@NP	et al. , 1997	35004
@NP	et al.	35004
@NP	1997	35012
@NP	OECs	35023
@NP	a cellular matrix	35040
@NP	axonal regeneration	35069
@NP	remyelinate residual axons	35108
@NP	Open-field locomotor behavior as scored on the BBB scale	35136
@NP	Open-field locomotor behavior	35136
@NP	the BBB scale	35179
@NP	the OEC transplantation group	35223
@NP	OECs	35716
@NP	a number	35729
@NP	trophic factors	35741
@NP	these events -LRB- Woodhall et al. , 2001 -RRB-	35782
@NP	these events	35782
@NP	Woodhall	35796
@NP	et al. , 2001	35805
@NP	et al.	35805
@NP	2001	35813
@NP	It	35820
@NP	a set of these mechanisms	35840
@NP	a set	35840
@NP	these mechanisms	35849
@NP	Our behavioral analysis	35880
@NP	5 weeks	35922
@NP	we	35943
@NP	significant shortterm functional improvement	35951
@NP	longer-term behavioral studies	35997
@NP	long-term functional improvement	36056
@NP	OECs	36090
@NP	an important cell candidate for cell transplantation strategies	36111
@NP	an important cell candidate	36111
@NP	cell transplantation strategies	36143
@NP	functional outcome	36186
@NP	adult spinal cord injury	36208
@NP	Clinical investigations in spinal cord injury using OEC engraftment	36234
@NP	Clinical investigations	36234
@NP	spinal cord injury using OEC engraftment	36261
@NP	spinal cord injury	36261
@NP	OEC engraftment	36286
@NP	progress -LRB- Senior , 2002 ; Huang et al. , 2003 -RRB-	36309
@NP	progress	36309
@NP	Senior , 2002 ; Huang et al. , 2003	36319
@NP	Senior	36319
@NP	2002 ; Huang et al.	36327
@NP	2002	36327
@NP	Huang et al.	36333
@NP	Huang	36333
@NP	et al.	36339
@NP	2003	36347
@NP	it	36363
@NP	appropriate cell preparation and transplantation conditions that functional	36397
@NP	appropriate cell preparation and transplantation conditions	36397
@NP	outcome	36473
@NP	OEC transplantation	36500
@NP	questions	36521
@NP	regard	36549
@NP	the in vivo fate of transplanted OECs	36559
@NP	the in vivo fate	36559
@NP	fate	36571
@NP	transplanted OECs	36579
@NP	the present study	36601
@NP	OECs	36620
@NP	the 5 week study period	36638
@NP	the transection lesion site	36693
@NP	axons forming myelin with at least a subpopulation of these axons	36751
@NP	axons	36751
@NP	at least a subpopulation of these axons	36777
@NP	at least a subpopulation	36777
@NP	these axons	36805
@NP	this myelination	36826
@NP	the observed functional recovery	36858
@NP	The relative contribution	36905
@NP	cellular repair	36934
@NP	trophic support	36957
@NP	endogenous recruitment	36977
@NP	cells , neuroprotection , and synaptic plasticity by OECs	37003
@NP	cells	37003
@NP	neuroprotection	37010
@NP	synaptic plasticity by OECs	37031
@NP	synaptic plasticity	37031
@NP	OECs	37054
@NP	a comprehensive evaluation of the potential therapeutic efficacy of OECs	37081
@NP	a comprehensive evaluation	37081
@NP	the potential therapeutic efficacy of OECs	37111
@NP	the potential therapeutic efficacy	37111
@NP	OECs	37149
@NP	a cell therapy in spinal cord injury	37157
@NP	a cell therapy	37157
@NP	spinal cord injury	37175
@NP	our understanding of potential trophic influences of OECs	37208
@NP	our understanding	37208
@NP	potential trophic influences of OECs	37229
@NP	potential trophic influences	37229
@NP	OECs	37261
@NP	this	37279
@NP	novel pharmacological approaches	37298
@NP	the treatment of spinal cord injury	37334
@NP	the treatment	37334
@NP	spinal cord injury	37351
@VP	were transplanted into a dorsal	617
@VP	transplanted into a dorsal	622
@VP	survived within the lesion zone	736
@VP	oriented longitudinally along axons that bridged the transection site	772
@VP	bridged the transection site	813
@VP	was within the lesion zone	883
@VP	distributed longitudinally outside of the lesion area	920
@VP	Myelinated axons spanning the lesion	975
@VP	spanning the lesion	992
@VP	were observed in discrete bundles encapsulated by a cellular element	1012
@VP	observed in discrete bundles encapsulated by a cellular element	1017
@VP	encapsulated by a cellular element	1046
@VP	immunostained with an anti-GFP antibody	1119
@VP	were derived from donor OECs	1225
@VP	derived from donor OECs	1230
@VP	was significantly improved in the OEC transplantation group	1285
@VP	improved in the OEC transplantation group	1303
@VP	derived from the adult olfactory bulb	1370
@VP	survive	1412
@VP	orient longitudinally across a spinal cord transection site and form myelin	1424
@VP	is associated with improved locomotion	1524
@VP	associated with improved locomotion	1527
@VP	undergo turnover from an endogenous progenitor pool	1623
@VP	grow through the olfactory nerves	1700
@VP	is delayed	2552
@VP	delayed	2555
@VP	Myelinated axons spanning the lesion site	2611
@VP	spanning the lesion site	2628
@VP	can integrate into injury sites and survive	3108
@VP	integrate into injury sites and survive	3112
@VP	integrate into injury sites	3112
@VP	survive	3144
@VP	form myelin or facilitate endogenous myelin repair mechanisms	3169
@VP	form myelin	3169
@VP	facilitate endogenous myelin repair mechanisms	3184
@VP	is controversial	3231
@VP	results in improved hindlimb locomotor function	3315
@VP	are diverse	3905
@VP	exhibit characteristics of astrocytes , SCs , and oligodendrocytes	3921
@VP	expressing transgenic rats into a dorsal funiculus transection model in the rat	4374
@VP	staining for GFP coupled with electron microscopy	4463
@VP	allowed ultrastructural identification of GFP myelin-forming cells	4513
@VP	integrate into the injury site of a dorsal funiculus transection	4614
@VP	distribute	4680
@VP	associate longitudinally with axons spanning the lesion site	4695
@VP	spanning the lesion site	4731
@VP	form myelin	4761
@VP	is associated with improved hindlimb locomotor function	4802
@VP	associated with improved hindlimb locomotor function	4805
@VP	to serially remove other cell types and obtain a highly pure population of OECs	5081
@VP	serially remove other cell types and obtain a highly pure population of OECs	5084
@VP	serially remove other cell types	5084
@VP	obtain a highly pure population of OECs	5121
@VP	dissected free of meninges	5317
@VP	to isolate the outer nerve	5447
@VP	isolate the outer nerve	5450
@VP	was minced finely with a pair scalpel blades -LRB- # 10 -RRB- on culture plastic	5492
@VP	minced finely with a pair scalpel blades -LRB- # 10 -RRB- on culture plastic	5496
@VP	washed from the culture dish	5597
@VP	was then centrifuged for 7 min at 300 x g	5916
@VP	centrifuged for 7 min at 300 x g	5925
@VP	was discarded	5975
@VP	discarded	5979
@VP	was immediately increased to 20 ml	6266
@VP	increased to 20 ml	6282
@VP	washed twice , resuspended	6473
@VP	preplated for 1 hr in a culture flask at 37 °C in a CO2 incubator	6504
@VP	were gently washed off with DMEM	6588
@VP	washed off with DMEM	6600
@VP	counting and concentrating cells to 3.0	6692
@VP	10 ^ 4 cells/µl just before transplantation	6734
@VP	were completed	6812
@VP	completed	6817
@VP	resuspended in 10 ml of culture media	6852
@VP	washed	6891
@VP	plated in 8-well poly-L-lysine-coated chamber slides inDMEMwith 10 %	6903
@VP	fixed for 10 min in icecold methanol	7028
@VP	incubated in primary antibody overnight at 4 °C	7069
@VP	used	7132
@VP	were counted in merged photographs with Hoechst nuclear staining	7950
@VP	counted in merged photographs with Hoechst nuclear staining	7955
@VP	approved all animal protocols	8245
@VP	were anesthetized with ketamine/xylazine -LRB- 90/4 mg/kg , i.p. -RRB-	8322
@VP	was performed	8425
@VP	performed	8429
@VP	was opened to expose the spinal cord	8449
@VP	opened to expose the spinal cord	8453
@VP	to expose the spinal cord	8460
@VP	expose the spinal cord	8463
@VP	was coagulated	8522
@VP	coagulated	8526
@VP	was transected -LRB- Neumann and Woolf , 1999 -RRB-	8563
@VP	transected -LRB- Neumann and Woolf , 1999 -RRB-	8567
@VP	were closed in layers with 4-0 nylon sutures	8706
@VP	closed in layers with 4-0 nylon sutures	8711
@VP	was allowed to recover on a 37 °C heating pad	8767
@VP	allowed to recover on a 37 °C heating pad	8771
@VP	to recover on a 37 °C heating pad	8779
@VP	recover on a 37 °C heating pad	8782
@VP	resulted in paresis of the hindlimbs in all animals subjected to the procedure	8826
@VP	subjected to the procedure	8878
@VP	did not impair eating , drinking , or elimination	8909
@VP	impair eating , drinking , or elimination	8917
@VP	derived from adult GFP-expressing rats , or vehicle alone -LRB- DMEM -RRB- ,	9056
@VP	were injected into the dorsal funiculus using a drawn glass micropipette	9121
@VP	injected into the dorsal funiculus using a drawn glass micropipette	9126
@VP	using a drawn glass micropipette	9161
@VP	made just rostral and two just caudal to the lesion at depths of 0.7 and 0.4 mm	9215
@VP	was made within the transection site for a total of five injections	9329
@VP	made within the transection site for a total of five injections	9333
@VP	was 1.0 µl per site	9419
@VP	was 3.0 x 10 ^ 4 cells/µl for a total of 1.5 x 10 ^ 5 cells transplanted per rat	9461
@VP	transplanted per rat	9517
@VP	were prepared for histological study at 5 weeks after transplantation	9551
@VP	prepared for histological study at 5 weeks after transplantation	9556
@VP	were perfused transcardially with PBS , followed by 4 % paraformaldehyde in PBS	9663
@VP	incubated with antibodies against neurofilament -LRB- NF ; 1:1000 ; Sigma , St.	9788
@VP	obtained from Dr.	9944
@VP	washed in PBS	10032
@VP	blocking solution for 2 hr	10227
@VP	washed in PBS	10255
@VP	mounted on slides	10274
@VP	included the omission of primary or secondary antibodies	10318
@VP	showed no staining	10375
@VP	dissected , postfixed overnight in 4 % paraformaldehyde	10822
@VP	dissected	10822
@VP	embedded in 3 % agar for vibratome sectioning	10881
@VP	were preincubated with 2 % normal goat serum for 30 min	10962
@VP	preincubated with 2 % normal goat serum for 30 min	10967
@VP	were collected from the lesion zone	11037
@VP	collected from the lesion zone	11042
@VP	were identified by fluorescence microscopy	11088
@VP	identified by fluorescence microscopy	11093
@VP	dehydrated in graded ethanol solutions , and embedded in Epox-812	11506
@VP	dehydrated in graded ethanol solutions	11506
@VP	graded ethanol solutions	11520
@VP	embedded in Epox-812	11550
@VP	cut on an ultramicrotome	11627
@VP	counterstained with uranyl and lead salts	11656
@VP	counterstained with uranyl	11656
@VP	lead salts	11687
@VP	operating at 80 kV	11775
@VP	were fixed	11831
@VP	fixed	11836
@VP	blocked	11843
@VP	described previously -LRB- Lankford et al. , 2002 -RRB-	11868
@VP	were collected at 0.25 mmintervals through the lesion	11955
@VP	collected at 0.25 mmintervals through the lesion	11960
@VP	counts	12014
@VP	were performed for axons within the lesion site	12297
@VP	performed for axons within the lesion site	12302
@VP	to identify specific pairwise differences between the means	12566
@VP	identify specific pairwise differences between the means	12569
@VP	were conducted using SPSS version 10.1.3	12647
@VP	conducted using SPSS version 10.1.3	12652
@VP	using SPSS version 10.1.3	12662
@VP	began 2 d before injury and was performed weekly for 5 weeks after surgery	12850
@VP	began 2 d before injury	12850
@VP	was performed weekly for 5 weeks after surgery	12878
@VP	performed weekly for 5 weeks after surgery	12882
@VP	to ensure reliability of hindlimb somatosensory testing	13071
@VP	ensure reliability of hindlimb somatosensory testing	13074
@VP	to assess treatment outcome	13131
@VP	assess treatment outcome	13134
@VP	was performed for between-group comparison for BBB analysis	13185
@VP	performed for between-group comparison for BBB analysis	13189
@VP	stained with methylene blue/Azure II	13307
@VP	was extensive in the transection site -LRB- B2 , B3 -RRB-	13610
@VP	was observed	13764
@VP	observed	13768
@VP	were intact -LRB- C2 , C3 -RRB-	13819
@VP	were in various stages of degeneration -LRB- C4 , C5 -RRB-	13855
@VP	indicated extensive colocalization	14174
@VP	, Sagittal frozen section showing	14368
@VP	showing	14394
@VP	Isolated fiber outside of the lesion zone	14470
@VP	associated with GFP fluorescence	14512
@VP	reveals intimate relationship between axons and GFP donor cells	14652
@VP	obtained from regions indicated in A.	15112
@VP	indicated in A.	15134
@VP	Note the clustering of myelinated axons surrounded by a cellular element	15202
@VP	surrounded by a cellular element	15242
@VP	showing myelinated axons surrounded by a cellular element forming a tunnel	15321
@VP	surrounded by a cellular element forming a tunnel	15346
@VP	forming a tunnel	15379
@VP	surrounding the bundle of myelinated axons	15474
@VP	observed in the extracellualar space -LRB- E -RRB-	15748
@VP	associated with cell membranes of some GFP-OECs -LRB- F -RRB-	15794
@VP	was observed within the transection site	15866
@VP	observed within the transection site	15870
@VP	was in close proximity to GFP donor cells	15911
@VP	are closely apposed to green cells	15997
@VP	apposed to green cells	16009
@VP	-LRB- in I -RRB- A -- C , 200µm ; D -- F , 20µm ; G -- I , 10µm	16095
@VP	is seen next to the labeled axon	16383
@VP	seen next to the labeled axon	16386
@VP	is shown in A2	16438
@VP	shown in A2	16441
@VP	showing cytoplastic reaction product	16494
@VP	is shown in B2	16562
@VP	shown in B2	16565
@VP	Note the presence of extracellular fibrous elements in B1	16578
@VP	showing GFP + and GFP - myelinated axons	16647
@VP	associated with GFP	16783
@VP	are not forming myelin	16831
@VP	forming myelin	16839
@VP	forming myelin	16895
@VP	surrounding an axon without myelin formation	16926
@VP	associated with axons	17006
@VP	indicate GFP + processes surrounding the cluster reminiscent of an A cell	17043
@VP	surrounding the cluster reminiscent of an A cell	17067
@VP	had a marked reduction in dCST axon density caudal to the lesion site	17616
@VP	was less for the OEC transplants	17705
@VP	reduced rostral to the lesion for both OEC transplant and sham injection groups	17774
@VP	was observed caudal to the lesion for both groups compared with control	17873
@VP	observed caudal to the lesion for both groups compared with control	17877
@VP	left to right , respectively	18047
@VP	tested 1 week before and for 5 weeks after transplantation	18165
@VP	is shown	18454
@VP	shown	18457
@VP	refer to comparison between intact control animals and the experimental groups	18478
@VP	refer to the significance between the DMEM and OEC groups	18578
@VP	were	18661
@VP	are given as means ± SEM	18725
@VP	given as means ± SEM	18729
@VP	± SEM	18744
@VP	can be seen in 1 µm plastic	18861
@VP	be seen in 1 µm plastic	18865
@VP	seen in 1 µm plastic	18868
@VP	composed of phagocytic cells -LRB- Fig. 1B3 -RRB-	19069
@VP	were observed -LRB- Fig. 1B5 -RRB-	19190
@VP	observed -LRB- Fig. 1B5 -RRB-	19195
@VP	surrounding the myelinated axons	19331
@VP	were preserved -LRB- Fig. 1C3 -RRB-	19580
@VP	preserved -LRB- Fig. 1C3 -RRB-	19585
@VP	was observed in the dCST -LRB- Fig. 1C4 , C5 -RRB-	19633
@VP	observed in the dCST -LRB- Fig. 1C4 , C5 -RRB-	19637
@VP	reported previously	19756
@VP	were generally larger than in intact animals	19811
@VP	were immediately prepared for tissue culture	20089
@VP	prepared for tissue culture	20106
@VP	attached and spread out slowly on poly-Llysine - coated chamber slides	20140
@VP	attached	20140
@VP	spread out slowly on poly-Llysine - coated chamber slides	20153
@VP	flattened fibroblastlike and astrocyte-like morphologies	20287
@VP	were also observed	20344
@VP	also observed	20349
@VP	coupled with Hoechst counterstaining of nuclei	20379
@VP	expressed GFAP -LRB- Fig. 2 -RRB-	20558
@VP	was examined in sagittal frozen sections of the spinal cord	20739
@VP	examined in sagittal frozen sections of the spinal cord	20743
@VP	survived	20810
@VP	elongated processes	21081
@VP	immunostained for NF	21360
@VP	showed a paucity of axons in the sham control	21560
@VP	revealed greater structural detail	21721
@VP	reported initially by Li et al. -LRB- 1997 -RRB-	21760
@VP	forming tube-like structures around the myelinated axons	21880
@VP	forming tunnels -LRB- Fig. 4D1 , D2 -RRB-	22297
@VP	variable from animal to animal and confined mostly to and near the lesion zone	22368
@VP	variable from animal to animal	22368
@VP	confined mostly to and near the lesion zone	22403
@VP	were present	22549
@VP	were observed in some regions of the lesion	22722
@VP	observed in some regions of the lesion	22727
@VP	were often associated with GFP cellular elements -LRB- Fig. 5G -- I -RRB-	22770
@VP	often associated with GFP cellular elements -LRB- Fig. 5G -- I -RRB-	22775
@VP	was performed	22889
@VP	performed	22893
@VP	to estimate the number of GFP + profiles that were associated with P0 rings	22966
@VP	estimate the number of GFP + profiles that were associated with P0 rings	22969
@VP	were associated with P0 rings	23011
@VP	associated with P0 rings	23016
@VP	identified rings	23055
@VP	were associated with GFP + profiles	23082
@VP	associated with GFP + profiles	23087
@VP	were not	23127
@VP	could not be identified	23148
@VP	be identified	23158
@VP	identified	23161
@VP	revealed that many detectable GFP cells were in direct contact with host axons	23323
@VP	were in direct contact with host axons	23364
@VP	forming peripheral-like myelin	23900
@VP	surrounded host axons but did not form myelin -LRB- Fig. 6D -RRB-	24085
@VP	surrounded host axons	24085
@VP	did not form myelin -LRB- Fig. 6D -RRB-	24111
@VP	form myelin -LRB- Fig. 6D -RRB-	24119
@VP	counting the number of GFP +	24261
@VP	had a relatively large number of myelinated axons	24370
@VP	associated with the method -LRB- see Discussion -RRB-	24518
@VP	see Discussion	24546
@VP	were obtained from the lesion center of a single transplant animal	24579
@VP	obtained from the lesion center of a single transplant animal	24584
@VP	identified a total of 131 GFP + cells	24683
@VP	showed no direct contact with axons	24761
@VP	could not be determined because of poor membrane preservation	24847
@VP	be determined because of poor membrane preservation	24857
@VP	determined because of poor membrane preservation	24860
@VP	could be identified	24951
@VP	be identified	24957
@VP	identified	24960
@VP	showed distinct myelin structure	24987
@VP	appeared to be in varying stages of wrapping or engulfing the axons	25057
@VP	to be in varying stages of wrapping or engulfing the axons	25066
@VP	be in varying stages of wrapping or engulfing the axons	25069
@VP	wrapping or engulfing the axons	25093
@VP	did not show distinct compact myelin	25129
@VP	show distinct compact myelin	25137
@VP	associated with myelin-forming cells that did not contain DAB reaction product	25248
@VP	did not contain DAB reaction product	25290
@VP	contain DAB reaction product	25298
@VP	displayed compact myelin	25356
@VP	were GFP + and 46 % were GFP	25386
@VP	were GFP	25404
@VP	GFP	25409
@VP	were GFP +	25534
@VP	was detected in the sham injection group -LRB- 64 ± 32 ; n = 7 -RRB-	25629
@VP	detected in the sham injection group -LRB- 64 ± 32 ; n = 7 -RRB-	25633
@VP	were observed in the OEC transplant group -LRB- 244 ± 50 ; n = 5 -RRB-	25714
@VP	observed in the OEC transplant group -LRB- 244 ± 50 ; n = 5 -RRB-	25719
@VP	counted from single sections at the specified regions	25782
@VP	repeated for multiple animals -LRB- n -RRB-	25840
@VP	averaged	25883
@VP	are consistent with expected anterograde degeneration of distal cut axons	26435
@VP	showed greater numbers of axons in the dCST at 2 mm caudal to the lesion	26557
@VP	Improved hindlimb locomotor function	26965
@VP	recovered to a BBB score of ≈ 9	27147
@VP	did not display weight-bearing plantar stepping	27183
@VP	display weight-bearing plantar stepping	27191
@VP	stepping	27222
@VP	recovered to 18 on the BBB score	27266
@VP	displayed consistent weight-bearing plantar stepping	27304
@VP	stepping	27348
@VP	was significantly higher than sham injection	27484
@VP	can promote axonal regeneration , remyelination , and functional recovery	27671
@VP	promote axonal regeneration , remyelination , and functional recovery	27675
@VP	associate with axons and form peripheral myelin	27990
@VP	associate with axons	27990
@VP	form peripheral myelin	28015
@VP	recruit endogenous SCs that form myelin	28054
@VP	form myelin	28082
@VP	to facilitate repair	28434
@VP	facilitate repair	28437
@VP	is clear that some degree of SC invasion associated with axonal repair can occur	28459
@VP	associated with axonal repair	28500
@VP	can occur	28530
@VP	occur	28534
@VP	might facilitate functional recovery	28573
@VP	facilitate functional recovery	28579
@VP	spanning the lesion	28823
@VP	are associated with myelin-forming cells	28876
@VP	associated with myelin-forming cells	28880
@VP	is facilitated by the OEC grafts	28991
@VP	facilitated by the OEC grafts	28994
@VP	indicate that the donor OECs are capable of forming myelin	29035
@VP	are capable of forming myelin	29064
@VP	forming myelin	29079
@VP	were associated with myelinated axons in the lesion zone	29133
@VP	associated with myelinated axons in the lesion zone	29138
@VP	used in the present study	29521
@VP	were more complex	29560
@VP	were less numerous than in the demyelinating X-EB lesion	29620
@VP	could readily be recognized	29713
@VP	be recognized	29727
@VP	recognized	29730
@VP	suggested that both can be derived from the donor OECs	30474
@VP	can be derived from the donor OECs	30494
@VP	be derived from the donor OECs	30498
@VP	derived from the donor OECs	30501
@VP	are associated with improved functional outcome -LRB- Takami et al. , 2002 -RRB-	30675
@VP	associated with improved functional outcome -LRB- Takami et al. , 2002 -RRB-	30679
@VP	is derived from the OEC transplantation	31133
@VP	derived from the OEC transplantation	31136
@VP	are derived exclusively from invading SCs	31194
@VP	derived exclusively from invading SCs	31198
@VP	invading SCs	31223
@VP	were forming peripheral-like myelin	31378
@VP	forming peripheral-like myelin	31383
@VP	involves a compromise between structural preservation and antibody penetration	31466
@VP	is limited	31596
@VP	were observed on an EM level	31662
@VP	observed on an EM level	31667
@VP	were associated with GFP + cells	31831
@VP	associated with GFP + cells	31836
@VP	did not contain DAB reaction product	31915
@VP	contain DAB reaction product	31923
@VP	caused by incomplete permeablization and poor penetration of antibodies	31983
@VP	contribute significantly to myelination of lesioned axons	32107
@VP	prepared at relatively high purity -LRB- > 95 % p75 + -RRB-	32221
@VP	not maintained in culture for extensive periods	32272
@VP	form peripheral-like myelin around axons spanning a dorsal funiculus transection	32332
@VP	spanning a dorsal funiculus transection	32373
@VP	may result from LacZ expression	32521
@VP	result from LacZ expression	32525
@VP	interfering with myelin synthesis	32598
@VP	argued against this possibility	32647
@VP	could limit detection	32789
@VP	limit detection	32795
@VP	used in the present study	32840
@VP	is robust and highly distributed in the cytoplasm of these cells	32866
@VP	distributed in the cytoplasm of these cells	32887
@VP	comparing results from OEC transplantation studies from various laboratories	32948
@VP	were transplanted	33173
@VP	transplanted	33178
@VP	used in the present study	33197
@VP	as assessed using p75/S100 immunostaining	33425
@VP	using p75/S100 immunostaining	33437
@VP	were used	33540
@VP	used	33545
@VP	were prepared from embryonic	33611
@VP	prepared from embryonic	33616
@VP	were used in those studies	33752
@VP	used in those studies	33757
@VP	did not use mitotic inhibitors	33833
@VP	use mitotic inhibitors	33841
@VP	did we stimulate proliferation and differentiation in vivo	33869
@VP	stimulate proliferation and differentiation in vivo	33876
@VP	are also p75/S100 positive , in our cultures	33957
@VP	are able to form	34060
@VP	to form	34069
@VP	form	34072
@VP	displaying a p75/S100 phenotype	34370
@VP	attempted to completely transect the dorsal funiculus	34547
@VP	to completely transect the dorsal funiculus	34557
@VP	completely transect the dorsal funiculus	34560
@VP	is the prospect that some residual axons may be present	34608
@VP	may be present	34649
@VP	be present	34653
@VP	were abundant within the lesion zone	34681
@VP	extended variable degrees outside of the transection zone	34722
@VP	was derived from donor cells	34840
@VP	derived from donor cells	34844
@VP	did not colocalize with NF staining	34874
@VP	colocalize with NF staining	34882
@VP	rather was observed in cells that associated with axons	34914
@VP	observed in cells that associated with axons	34925
@VP	associated with axons	34948
@VP	to promote axonal regeneration or sprouting	35058
@VP	promote axonal regeneration or sprouting	35061
@VP	sprouting	35092
@VP	scored on the BBB scale	35169
@VP	was significantly improved in the OEC transplantation group	35193
@VP	improved in the OEC transplantation group	35211
@VP	could contribute to these events -LRB- Woodhall et al. , 2001 -RRB-	35762
@VP	contribute to these events -LRB- Woodhall et al. , 2001 -RRB-	35768
@VP	is possible that a set of these mechanisms is operative	35823
@VP	is operative	35866
@VP	was performed for 5 weeks	35904
@VP	performed for 5 weeks	35908
@VP	show significant shortterm functional improvement	35946
@VP	will be necessary to assess long-term functional improvement	36028
@VP	be necessary to assess long-term functional improvement	36033
@VP	to assess long-term functional improvement	36046
@VP	assess long-term functional improvement	36049
@VP	to improve functional outcome in adult spinal cord injury	36175
@VP	improve functional outcome in adult spinal cord injury	36178
@VP	using OEC engraftment	36280
@VP	are in progress -LRB- Senior , 2002 ; Huang et al. , 2003 -RRB-	36302
@VP	can be enhanced by OEC transplantation	36481
@VP	be enhanced by OEC transplantation	36485
@VP	enhanced by OEC transplantation	36488
@VP	remain with regard to the in vivo fate of transplanted OECs	36537
@VP	survived for the 5 week study period	36625
@VP	integrated within	36663
@VP	spanned the transection lesion site	36685
@VP	forming myelin with at least a subpopulation of these axons	36757
@VP	contributes to the observed functional recovery	36843
@VP	is uncertain	36891
@VP	is expanded	37266
@VP	expanded	37269
@VP	suggest novel pharmacological approaches to the treatment of spinal cord injury	37290
